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(i) 
Systemic lupus erythematosus (SLE) is a peculiar 
autoimmune disorder characterized by the production of anti-
native DNA antibodies. The origin of these antibodies and 
the etiology of SLE has not yet been known. Anti-DNA human 
autoantibodies show a wide spectrum polyreactivity 
characterized by their binding with nucleic acids of varying 
source, size and conformations. The binding of these 
antibodies to reactive oxygen species (ROS), modified DNA, 
DNA-psoralen adduct, brominated DNA, RNA-DNA hybrids and 
various single and double stranded polymers has been 
reported from various studies. These antibodies also 
recognize structures other than nucleic acids, e.g. 
cardiolipin, polylysine and polylysine-polyglutamate 
complex. Analysis of DNA from SLE patient's plasma has 
revealed that these molecules are 100-1000 base pair long 
and rich in G=C sequences. Such molecules can undergo B-to 
Z- transition under constrained conditions. SLE is 
predominantly found in females of child bearing age. 
Frequent exacerbation of disease during pregnancy or 
following oral contraceptive therapy strongly suggest the 
influence of sex hormones on disease activity. 
In the present study conformational transition in 
native calf thymus DNA was induced by bromination under high 
and low salt conditions and by interaction with polyamines. 
Attainment of Z-form by native calf thymus DNA was analyzed 
(ii) 
by UV and CD spectroscopic techniques. When compared with 
the spectrum of native DNA, the high salt brominated form 
exhibited hypochromicity at 260 nm and hyperchromicity at 
around 295 nm in UV spectral analysis. The changes were 
less pronounced in the case of native DNA brominated under 
physiological conditions of saline. These spectral changes 
indicate that native DNA brominated in high salt has 
attained left handed Z-conformation. The results were 
substantiated by the absorbance ratio (A295/A2go) °f 0.35 in 
the case of native DNA brominated in high salt, while this 
ratio was 0.188 for the low salt brominated polymer. 
Absorbance ratio of 0.3 is a characteristic feature of 
prototype Z-DNA. Additional evidence for the attainment of 
Z-form by brominated DNA (4.0 M NaCl) was provided by the 
inversion of DNA spectrum in CD spectroscopy. This inversion 
was absent in the case of low salt brominated sample. 
Formation of Z-/Z-lik;e DNA as a result of interaction 
with polyamines was detected by absorbance ratio and binding 
with anti-Z-DNA antibodies. The specific binding of anti-Z-
DNA antibodies to polyamine-DNA complex provided the 
evidence for conformational isomerization of native B-
epitopes into Z-conformation in the presence of increasing 
concentration of polyamines. 
Small size DNA fragments were obtained as a result of 
controlled digestion with micrococcal nuclease. The 
approximate fragment size was determined by standard DNA 
marker. Native DNA (average size 2oo bp) was separately 
linked to estradiol-albumin (E2-BSA) and bovine serum 
albumin (BSA). Glutaraldehyde was used for covalent 
coupling. The separation of linked and unlinked species was 
achieved by gel exclusion chromatography on Sephadex G-200 
column. The BSA-DNA and E2-BSA-DNA conjugates were 
characterized by ultraviolet spectroscopy wherein a red 
shift of 8 nm and 11 nm in the minima was respectively 
observed for DNA-BSA and E2-BSA-DNA conjugates. 
Structural change or perturbations in native DNA and 
native DNA (-200 bp) as a result of modification were also 
checked by mid-point melting temperature (Tm) analysis and 
evaluation of various thermodynamic parameters. As revealed 
by the values for Gibb's free energy ( A Gp), all the 
modified forms, with the exception of DNA-BSA conjugate, 
were thermodynamically stable than their corresponding DNA 
controls. 
Antibodies against E2-BSA, E2-BSA-DNA and DNA-BSA 
conjugates were raised in rabbits. Direct binding ELISA 
showed a titer> 1:12800 for anti-E2-BSA and anti-E2-BSA-DNA 
antibodies. The DNA-BSA conjugate induced antibodies with a 
titer greater than 1:1600. The specificity of induced 
antibodies was confirmed in inhibition ELISA by using the 
respective immunogens as inhibitors in each case. The 
(iv) 
antibody diversity was checked by using various inhibitors 
like estradiol, BSA, poly(rG).poly(dC), histone, native DNA, 
ssDNA, RNA and Br-DNA. The results indicated poor cross-
reactivity of the induced antibodies suggesting their 
specificity towards their respective immunogens. Only anti-
E2-BSA-DNA antibodies recognized heat denatured DNA (ssDNA) 
and RNA. Estradiol was inhibitory for both anti-E2-BSA and 
anti-E2-BSA-DNA antibodies. 
The binding specificity of naturally occurring anti-DNA 
antibodies with various modified forms of DNA was analyzed 
by direct binding and competition ELISA. The SLE anti-DNA 
antibodies appreciably recognized the Z-conformation induced 
either as a result of bromination in high salt or through 
interaction with polyamines. The degree of binding of these 
antibodies to either of the induced Z-conformation was 
almost similar to their binding with native DNA. Two unique 
findings were made, for the first time, in this study. One, 
the binding of E2-BSA-DNA conjugate to naturally occurring 
anti-DNA antibodies derived from the sera of various SLE 
patients; indicating thereby the recognition of altered 
conformation of the modified polymer. Second, the enhanced 
recognition of ^-estradiol, coit^ jared to native DNA, by 
autoantibodies present in the sera of SLE patients as well 
as by anti-DNA IgG purified from various SLE sera on DNA-
[polylysyl-Sepharose 4B] affinity column. 
(V) 
In conclusion, native DNA and small size DNA fragments 
have interspersed base pair sequences which have the 
potential to undergo B-to Z- or Z-like transition. These 
conformationally altered segments could be acting as 
autoantigens for the etiopathogenesis of SLE. The results 
also draw attention towards the possible role of female sex 
hormone in the induction of anti-DNA response, the 
characteristic feature of SLE. 

!( I --
'-A 
'^ • . 
- / . - t 
U ^ \^l' 
.^^.s^a.ows,,^^ 
(•<• x\0. 
,- r-4^(9 04 
.<^' 
5 -
T4804 
CERTIFICATE 
I certify that the work presented in the following 
pages has been carried out by Moinuddin and is suitable for 
the award of Ph.D. degree in Biochemistry of the Aligarh 
Muslim University, Aligarh. 
(DR.^XSiF ALI) 
Reader 
Department of Biochemistry 
J.N. Medical College 
Aligarh Muslim University 
ALIGARH 202002 
INDIA 
fo mm 
c/ a/}^€^nii^ <m<i 
ACKNOWLEDGEMENTS 
I am profoundly indebted to my supervisor, Dr. As if 
Ali, for his sustained interest and guidance throughout the 
course of this research study. My frequent discussions with 
him gave me a deeper insight into the problem of 
investigation. His valuable suggestions helped me a lot at 
all levels of the study. Without his able guidance I might 
have encountered many a pitfall in conducting this research 
work. 
I also owe a dept of gratitude to Prof. Rashid Ali, 
chairman of the department, who has been a great source of 
inspiration, encouragement and help to me during the entire 
period of my research work. He was kind enough to give me 
the liberty to encroach upon his precious time despite his 
numerous academic and administrative preoccupations. 
I express my thanks to Prof. A. Salahuddin, Drs. W.A. 
Naqvi, M.A. Qasim, M.U. Siddiqui, (Mrs) K.A. Salman, A.F. 
Faizi, Najmul Islam and Khurshid Alam for their cooperation. 
I am thakful to Prof. A.M. Siddiqui, Prof. M. 
Saleemuddin, Prof. S.M. Hadi, Drs. A.N.K. Yusufi, Masood 
Ahmad and Riaz Mahmood of the department of Biochemistry, 
Faculty of Life Sciences, A.M.U. for their encouragement and 
timely advice. Thanks also go to all my teachers for my 
academic nurturing. 
Thanks are also due to my senior colleagues, Drs. 
Naushad Ali, Jahan Ara, Zarina Arif and (Mrs) Vandana Sehgal 
for their love and cooperation. 
I am priviledged to thank my research colleagues Ms. 
Sadia Arjumemd, Mr. B.T. Ashok, Ms. Jabeen Ahmad, Ms. Subia 
Tasneem, Mr. Ghulam Waris, Mr. Deepak Kumar, Ms. Shaheen 
Khatoon and Ms. Nabiha Yusuf for their cooperation and 
constructive scientific discussions. I would also like to 
put on record the help extended to me by Mr. Nisar Ahmad, 
Mr. N. Khan, Mr V.D. Trivedi, Mr. F.H. Khan, Ms. Indu Saxena 
and Ms. Humra Athar. 
J will be failing in my duty if I do not acknowledge 
Prof. A.N. Malaviya and Dr. Ira Pande of the Department of 
Medicine, A.I.I.M.S, New Delhi for providing the sera of SLE 
patients. 
I am thankful to non teaching staff of the department 
for their constant help. 
Lastly, I wish to thank M/s. Indo Laser Print for the 
Painstaking typing work and Mr. Saleemuddin for 
cartiographic work. Help extended by the staff of Central 
Photography Section is highly appreciated. 
rvv L ^.a>L^\^ 
(MOINUSDIN) 
CONTENTS 
PAGE NO. 
ABSTRACT [i] 
ABBREVIATIONS [vi] 
LIST OF FIGURES [vii] 
LIST OF TABLES [x] 
INTRODUCTION [1] 
EXPERIMENTAL [44] 
RESULTS [72] 
DISCUSSION [138] 
REFERENCES [153] 

(i) 
Systemic lupus erythematosus (SLE) is a peculiar 
autoimmune disorder characterized by the production of anti-
native DNA antibodies. The origin of these antibodies and 
the etiology of SLE has not yet been known. Anti-DNA human 
autoantibodies show a wide spectrum polyreactivity 
characterized by their binding with nucleic acids of varying 
source, size and conformations. The binding of these 
antibodies to reactive oxygen species (ROS), modified DNA, 
DNA-psoralen adduct, brominated DNA, RNA-DNA hybrids and 
various single and double stranded polymers has been 
reported from various studies. These antibodies also 
recognize structures other than nucleic acids, e.g. 
cardiolipin, polylysine and polylysine-polyglutamate 
complex. Analysis of DNA from SLE patient's plasma has 
revealed that these molecules are 100-1000 base pair long 
and rich in G=C sequences. Such molecules can undergo B-to 
Z- transition under constrained conditions. SLE is 
predominantly found in females of child bearing age. 
Frequent exacerbation of disease during pregnancy or 
following oral contraceptive therapy strongly suggest the 
influence of sex hormones on disease activity. 
In the present study confoirmational transition in 
native calf thymus DNA was induced by bromination under high 
and low salt conditions and by interaction with polyamines. 
Attainment of Z-form by native calf thymus DNA was analyzed 
(ii) 
by UV and CD spectroscopic techniques. When compared with 
the spectrum of native DNA, the high salt brominated form 
exhibited hypochromicity at 260 nm and hyperchromicity at 
around 295 nm in UV spectral analysis. The changes were 
less pronounced in the case of native DNA brominated under 
physiological conditions of saline. These spectral changes 
indicate that native DNA brominated in high salt has 
attained left handed Z-conformation. The results were 
substantiated by the absorbance ratio (-^295^250) of 0-35 in 
the case of native DNA brominated in high salt, while this 
ratio was 0.188 for the low salt brominated polymer. 
Absorbance ratio of 0.3 is a characteristic feature of 
prototype Z-DNA. Additional evidence for the attainment of 
Z-form by brominated DNA (4.0 M NaCl) was provided by the 
inversion of DNA spectrum in CD spectroscopy. This inversion 
was absent in the case of low salt brominated sample. 
Formation of Z-/Z-like DNA as a result of interaction 
with polyamines was detected by aJDSorbance ratio and binding 
with anti-Z-DNA antibodies. The specific binding of anti-Z-
DNA antibodies to polyamine-DNA complex provided the 
evidence for conformational isomerization of native B-
epitopes into Z-conformation in the presence of increasing 
concentration of polyamines. 
Small size DNA fragments were obtained as a result of 
controlled digestion with micrococcal nuclease. The 
(iii) 
approximate fragment size was determined by standard DNA 
marker. Native DNA (average size 2oo bp) was separately 
linked to estradiol-albumin (E2-BSA) and bovine serum 
albumin (BSA). Glutaraldehyde was used for covalent 
coupling. The separation of linked and unlinked species was 
achieved by gel exclusion chromatography on Sephadex G-200 
column. The BSA-DNA and E2-BSA-DNA conjugates were 
characterized by ultraviolet spectroscopy wherein a red 
shift of 8 nm and 11 nm in the minima was respectively 
observed for DNA-BSA and E2-BSA-DNA conjugates. 
Structural change or perturbations in native DNA and 
native DNA (-200 bp) as a result of modification were also 
checked by mid-point melting temperature (Tm) analysis and 
evaluation of various thermodynamic parameters. As revealed 
by the values for Gibb's free energy ( AGJ-,) , all the 
modified forms, with the exception of DNA-BSA conjugate, 
were thermodynamically stable than their corresponding DNA 
controls. 
Antibodies against E2-BSA, E2-BSA-DNA and DNA-BSA 
conjugates were raised in rabbits. Direct binding ELISA 
showed a titer> 1:12800 for anti-Ej-BSA and anti-E2-BSA-DNA 
antibodies. The DNA-BSA conjugate induced antibodies with a 
titer greater than 1:1600. The specificity of induced 
antibodies was confirmed in inhibition ELISA by using the 
respective immunogens as inhibitors in each case. The 
(iv) 
antibody diversity was checked by using various inhibitors 
like estradiol, BSA, poly(rG).poly(dC), histone, native DNA, 
ssDNA, RNA and Br-DNA. The results indicated poor cross-
reactivity of the induced antibodies suggesting their 
specificity towards their respective itnmunogens. Only anti-
E2-BSA-DNA antibodies recognized heat denatured DNA (ssDNA) 
and RNA. Estradiol was inhibitory for both anti-E2-BSA and 
anti-E2-BSA-DNA antibodies. 
The binding specificity of naturally occurring anti-DNA 
antibodies with various modified forms of DNA was analyzed 
by direct binding and competition ELISA. The SLE anti-DNA 
antibodies appreciably recognized the Z-conformation induced 
either as a result of bromination in high salt or through 
interaction with polyamines. The degree of binding of these 
antibodies to either of the induced Z-conformation was 
almost similar to their binding with native DNA. Two unique 
findings were made, for the first time, in this study. One, 
the binding of E2-BSA-DNA conjugate to naturally occurring 
anti-DNA antibodies derived from the sera of various SLE 
patients; indicating thereby the recognition of altered 
conformation of the modified polymer. Second, the enhanced 
recognition of S-estradiol, compared to native DNA, by 
autoantibodies present in the sera of SLE patients as well 
as by anti-DNA IgG purified from various SLE sera on DNA-
[polylysyl-Sepharose 4B] affinity column. 
(v) 
In conclusion, native DNA and small size DNA fragments 
have interspersed base pair sequences which have the 
potential to undergo B-to Z- or Z-like transition. These 
conformationally altered segments could be acting as 
autoantigens for the etiopathogenesis of SLE. The results 
also draw attention towards the possible role of female sex 
hormone in the induction of anti-DNA response, the 
characteristic feature of SLE. 
(vi) 
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Ever since it was first isolated from pus cell nuclei 
(Miescher, 1879), the DNA has occupied a centre stage in 
various biochemical investigations. In fact the modern era 
of molecular biology began with the elucidation of double 
helical structure of DNA (Watson and Crick, 1953) by the 
detailed analysis of diffraction pattern and by careful 
molecular modelling. While this model of DNA, also known as 
B-DNA is regarded as the most accepted structure of DNA 
molecule in solution, more sophisticated x-ray diffraction 
studies have thrown light on various alternative 
conformations of DNA such as A- and C-DNA within the right 
handed family (Adams et al., 1981) (Table l). This 
conformational flexibility has been the most important 
feature of the double helix. It is a dynamic structure which 
can adopt multiple conformations depending on its 
bioenvironment. These alternate conformations are likely to 
play a crucial role in gene expression by increased or 
decreased synthesis of regulatory proteins. Over the last 
few years important progress has been made in understanding 
the nature of DNA fine structure. Since the first direct 
demonstration of sequence dependent heterogeneity by single 
crystal x-ray analysis (Dickerson and Drew, 1981), many 
experimental techniques have demonstrated the effects of 
base sequence on the properties of DNA. Certain base 
sequences can give rise to very particular conformations and 
TABLE 1 
Different Conformations of Right-Handed DNA 
Form Pitch 
(A°) 
Residue 
per turn 
Inclination 
of base pair 
from horizontal 
A (Na-salt, 75% 28 
relative humidity) 
B (Na-salt, 92% 34 
relative humidity) 
C (Li-salt, 66% 31 
relative humidity) 
RNA-DNA hybrid 28 
11 
10 
9.3 
11 
20" 
20' 
Source : Adams et al. (1981) 
may also influence the local flexibility of the DNA double 
helix. DNA is no longer considered a static molecule, but 
rather, a dynamic structure in which different conformations 
are in equilibrium with each other (Rich et al. , 1984; 
Pecheneya, 1993) . It has now become clear that 
conformational diversity of the DNA helix may play an 
important role in the recognition of DNA binding sites by 
proteins and other important biomolecules (Synder et al., 
1986; Zahn and Blatter, 1987; Stenzel et al., 1987). The 
static image of DNA-protein interaction has been replaced by 
a more global and dynamic view in which proteins and other 
molecules recognize the overall 3-dimensional form of DNA, 
its local flexibility and both the interacting partners can 
undergo considerable structural modification at the moment 
of complex formation (Drew and Travers, 1984; Majumdar and 
Adhya, 1989). Antibodies generated against various modified 
conformations of DNA can act as a tool to probe the presence 
of these forms in the body. 
Antigenicity of DNA 
Antibodies to DNA (anti-DNA) were first reported in the 
sera of patients with systemic lupus erythematosus in 1957. 
Since then the immunogenecity of nucleic acids has received 
considercible attention. Native DNA in B-conformation is non-
immunogenic despite the fact that most nucleic acids elicit 
the formation of antibodies (Stollar, 1986) . Even MRL mice. 
which are genetically programmed to "spontaneously" produce 
anti-B-DNA antibodies do not respond to exogenous DNA and 
fail to elicit high levels of antibody against double 
stranded DNA (Hughes, 1986) . Animals immunized with DNA show 
only limited antibody production, almost exclusively 
directed against single stranded DNA (Plescia et al., 1964). 
A decisive breakthrough in the production of anti-DNA 
antibodies was reported in 1960 by Levine et al. They 
successfully elicited antibodies directed to the denatured 
(single stranded) DNA of T- even bacteriophage. The 
antibodies were directed to the modified base of these 
phages as only they seemed essential for the production of 
antibodies, because immunization with purified DNA having 
normal bases yielded little or no antibody. Two general 
methods for the generation of anti-nucleic acid antibodies 
have been experimentally demonstrated (Plescia et. al., 
1964). One is the use of bases, nucleosides and nucleotides 
as haptens (Erlanger and Beiser, 1964). The resulting 
antibodies react with denatured DNA with considerable 
selectivity for the corresponding purine and pyrimidine 
bases. The second general method is the formation of 
immunogenic complexes of nucleic acid and a positively 
charged protein carrier (Plescia et al., 1964). This has 
provided an immunogenic stimulus for denatured DNA, 
synthetic homopolynucleotides, chemically modified DNA and 
certain helical synthetic polynucleotides. Effective helical 
immunogens in this form have been double stranded RNA, RNA-
DNA hybrids, left handed Z-DNA, triple helical RNA and DNA 
analogues and double helical polydeoxyribonucleotides that 
differ from B-DNA, such as poly(dG).poly(dC) (Stollar, 1973; 
1975; 1986; Anderson, 1988) . An important property of the 
resulting antibodies is that they do not recognize B-
conformation of DNA. Immunization with nucleic acid-MBSA 
(methylated BSA) complexes generally has not been effective 
for native DNA, tRNA or ribosomal RNA (Stollar, 1989) . 
Antibodies of high selectivity have been induced by left 
handed Z-DNA and these antibodies have served as a tool for 
the identification of Z-DNA in chromosomes (Lafer et al 
1981, Stollar, 1986). Injection of histone-DNA complexes 
yielded some anti-histone but not anti-DNA antibodies 
(Stollar and Ward, 1970), nor did immunization with isolated 
nucleosomes induce anti-DNA response (Einck et al., 1982) . A 
duplex DNA, poly(dT-dC).poly (dG-dA) was used by Lee et al. 
(1985) to generate monoclonals. The antibodies so obtained 
gave a weak cross reaction with native calf thymus DNA. A 
monoclonal IgM antibody selective for native DNA was 
obtained from a mouse immunized with DNA and several 
different synthetic DNA analogues (Huang et al., 1985). 
Recently it was observed that, injection of bacterial native 
DNA into normal mice induced antisera that bound native 
bacterial but not the mammalian DNA (Gilkeson et al., 1989). 
Injection of BK virus into rabbits induced antibody to both 
native DNA and histone (Flaegstad et al., 1988). A much 
smaller population of antibodies against native DNA was 
obtained by immune- purifying the antibodies generated 
against deoxyribonucleotide-protein conjugate, prepared 
with the help of water soluble carbodiimides (Jacob and 
Jacob, 1985) . 
Antibodies have also been generated against chemically 
modified and triple helical DNA. Immunization with 
methylated BSA complexes of modified DNA, as with cisplatin-
modified DNA (Poirier, 1981; Sundquist et al., 1987) or 
with modified nucleosides or nucleotides conjugated to 
proteins has led to the induction of antibodies (Muller and 
Rajewsky, 1980) . A triple helical DNA can be formed at 
neutral pH by a mixture of poly (dT-dm^C) and poly (dG-dA) 
(Lee et al., 1980). Monoclonal antibodies generated against 
this complex polymer, recognized the antigen but failed to 
react with other related polynucleotides that cannot form a 
triple helix (Lee et al., 1987). As with other nucleic acid 
configurations, the antibodies generated either against 
chemically modified DNA or against triple helical DNA do not 
react with native B- helical DNA. 
Recently it has been found that sera from normal 
subjects showed binding to highly purified double-stranded 
(ds) DNA from Micrococcus lysodeikticus (Bunyard and 
Pisetsky, 1994) . The results indicate that sera from normal 
human subjects have antibodies which bind bacterial ds DNA 
and extend the range of determinants that can be recognized 
as foreign by the normal immune system. To explain this 
response, it has been postulated that bacterial DNA can 
induce antibody production during infection because of 
sequences rarely present in host DNA and therefore 
recognized as foreign (Pisetsky et al., 1990). 
Conformational Substates in B-DNA 
Native DNA in B-form is a poor immunogen. Certain right 
handed helical double stranded polydeoxy-ribonucleotides 
differ slightly from the average B-DNA helix and are 
immunogenic beyond the adjuvant induced autoantibody 
expansion (Madaio et al. , 1984). The immunogenicity is 
itself an indication of their having a structure other than 
the B-form. They elicit antibodies that recognize the 
differences. between them and native B-DNA. The antibodies 
have been found to react with the immunogen, but their 
binding to native DNA is either very weak or not at all. 
This again points towards the existence of structural 
differences between the helices. These immunogenic analogues 
of natural B-form of DNA include, poly(dG). poly(dC) 
(Stollar, 1970); poly{dG-dA). poly(dT-dC) (Lee et al. , 
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1985); poly.(dA). poly (dT) (Arnott et al. 1983; Diekmann 
and Zarling, 1987); poly(dG-dC) (Zarling at al., 1987). The 
other right handed structures within naturally occurring DNA 
which arise as a result of change in humidity and salt 
conditions are A- and C-DNA (Arnott and Hukin, 1972; Arnott 
and Seising, 1975; Saengar, 1984). Under conditions, such as 
addition of ethanol or trifluoroethanol, which decreases 
water activity, the B->A transition can be induced in 
solution (Ivanov and Krylov, 1992) . The A- configuration is 
also found in double stranded RNA and RNA-DNA hybrid 
(Spencer et al., 1962; Milman et al., 1967). There is strong 
evidence that the conformation of poly(dG) . poly (dC) in 
solution is A-like (Arnott and Seising, 1974; Sarma et al., 
1986). The proposal of Stafford and Donnellan (1968), that 
DNA in dormant spores of Bacillus species is entirely in an 
A-like conformation, has still been found valid and has been 
reviewed in the light of recent evidences (Setlow, 1992) . 
Relatively short stretches of the sequence (dC-dA)j^ . (dG-
dT)jj, which is the most abundant purine-pyrimidine 
dinucleotide repeat in eukaryotic genome, have been found in 
all eukaryotes, from yeast to human beings (Hamada et al. , 
1982; Weber 1990) . Studies on potential Z-forming sequence 
(dT-dG)j^ , (dC-dA)jj has revealed evidence for an "alternating 
B" conformation on the nucleosomal surface (Gross et al. , 
1985). It is possible that the alternative helical structure 
of these sequences yields a distinctive structure in the 
nucleus that is recognized by proteins functioning in 
recombination and replication events. Because these 
sequences exhibit length polymorphism, they represent a new 
rich source of informative genetic markers (Weber and May, 
1989). An "alternating B" structure has been proposed for 
poly(dA-dT). poly(dA-dT) in solution. This structure is 
based on DNase I cleavage pattern, proton and -^  P nuclear 
magnetic resonance (NMR) spectroscopy, and X-ray fiber 
diffraction (Klug et al. , 1979). The synthetic 
deoxyoctanucleotide (G-G-G-G-T-C-C-C) crystallizes as an A-
type DNA double helix containing two adjacent G-T base pair 
mismatches (Kneale et al. , 1985). Also, the potentially Z-
DNA forming sequence d(GTGTACAC) crystallizes as A-DNA (Jain 
et al. , 1987). Poly (dG) . poly(dC) sequences, under 
torsional stress, induce an altered DNA conformation upon 
neighbouring DNA sequences and such altered DNA structures 
may play an important role in chromatin function (Shigematsu 
and Kohwi, 1985). Studies on DNA-drug interaction have shown 
that because of drug binding, a fraction of DNA is locked in 
the B-form and is incapable of adopting the A-form even 
under conditions of rigorous dehydration (Fritzsche, 1991; 
1994) . 
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Left Handed Double Helical DNA 
DNA is a very dynamic molecule which can adopt both 
right handed and left handed conformations. This is of 
considerable interest as biological function at molecular 
level is often closely related with the structure. A number 
of variations of the basic structure of DNA, i.e. the B-
form, have been described in which there is some alteration 
in the form of the molecule. An alternate purine-pyrimidine 
copolymer, poly{dG-dC). poly(dG-dC) has been shown to 
undergo salt induced conformational transition in neutral 
solution (Pohl and Jovin, 1972) and in 50% ethanol (Pohl, 
1976) . The left handed form has also been described in a 
single crystal of a DNA fragment containing six base pairs 
with the sequence d(CpGpCpGpCpG) (Wang et al.,1979). The 
crystal contained magnesium and spermine as cations. The 
ribose phosphate backbone in the left handed double helical 
form pursues a zigzag course, leading to the name, Z-DNA. It 
is a prototype left handed double helix whose structural 
properties differ significantly from those of the classical 
B-form. 
Studies carried out for the formation of Z-DNA in vitro 
have been successful in inducing conformational transition 
in various right handed polynucleotides. The linear duplex 
(dG-dC)n can undergo B->Z transition at NaCl concentration 
above 2.25M (Klysik et al., 1981; Pohl, 1983) or as a result 
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of modification of either guanine or cytosine residues (Sage 
and Leng, 1980; Behe and Felsenfeld, 1981; Klysik et al. , 
1983). Other DNA sequences with alternating purine-
pyrimidine residues, including poly(dA-S dT) and poly(dT-
dG).poly(dC-dA), exhibit fiber structures that are 
compatible with left handed Z-form as well (Arnott et al. , 
1980). Poly(dG-m^dC) converts readily to left handed Z-DNA 
in vitro in the presence of millimolar concentrations of 
divalent metals and polyamines, as well as small peptides 
(Behe and Felsenfeld, 1981; Rich et al., 1984; Takeuchi et 
al., 1991). The above sequences and certain others that 
contain alternating purine-pyrimidine sequences can adopt 
the Z-conformation in response to negative supercoiling or 
elevated ionic strength (Peck et al., 1982; Gross et al. , 
1985) . 
It has been shown that different lysine rich histones 
can cause varying conformational changes in the condensation 
of chromatin in DNA regions of highly biased base sequence 
(Mura and Stollar, 1984). In addition, naturally occurring 
polyamines, putrescine, spermidine and spermine can induce B 
to Z transition of poly(dG-m^dC).poly(dG-m^dC) at micromolar 
concentrations (Behe and Felsenfeld, 1981; Thomas et al. , 
1985). B to Z transition has also been reported in poly (dA-
dC) . poly (dG-dT) at low ionic concentrations in the 
presence of spermidine and spermine (Thomas and Messner, 
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1986) . While most of the conditions used to induce Z-DNA 
formation in the laboratory are not physiologic, polyamines 
can induce and stabilize Z-DNA form of conformationally 
labile polynucleotides under physiologically relevant cation 
concentrations (Thomas et al., 1985; Thomas and Messner, 
1988). Hasan and Ali (1990) reported the presence of Z-like 
features in calf thymus DNA that was brominated under high 
salt (4M NaCl) conditions. 
Various studies performed on conformationally different 
polynucleotides under elevated ionic conditions have 
successfully described the attainment of Z-conformation. The 
question that now strikes our mind is whether Z-DNA can 
occur in vivo or not. A number of studies suggest that Z-DNA 
may exist in vivo (Jaworski et al., 1987; Rahmouni and 
Wells, 1989; Wittig et al., 1989; Rahmouni, 1992), however, 
the extent of its occurrence is yet to be determined. Inside 
the cell, Z-conformation can be induced as a result of 
negative supercoiling which is generated during 
transcription (Liu and Wang, 1987; Tsao et al . , 1989). 
Furthermore, the equilibrium between B and Z-DNA can be 
influenced by proteins that preferentially bind to one of 
the two conformations (Lafer et al., 1985). Z-DNA has been 
implicated in some important biological processes, such as 
general DNA recombination (Bullock et al., 1986; Treco and 
Arnheim, 1986; Blaho and Wells, 1987; Wahls et al., 1990), 
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and both positive and negative transcriptional regulation 
(Nordheim and Rich, 1983; Naylor and Clark, 1990) . There are 
many approaches that can be adopted to further understand 
the biological significance of Z-DNA in vivo. One approach 
is purification and in vitro characterization of a protein 
that has got enhanced affinity for left handed DNA. Zhang et 
al. (1992) have purified and characterised a putative Z-DNA 
binding protein, Zuotin, in Saccharomyces cerevisiae. 
Recently, it has been reported that upon a linear increase 
of the ionic strength, the hexadecamer d(C-G)g undergoes the 
expected B to Z transition, which is completed at 2.0 M 
MgCl2• But as the salt concentration is raised above 2.0 M, 
a second structural transition from Z-DNA back to right 
handed B-DNA is observed. This Z to B transition can be 
induced by divalent ions (e.g. CaCl2, MgCl2) but not by 
monovalent NaCl (Reich et al., 1993). 
Immunochemical studies have revealed that Z-DNA is a 
powerful immunogen eliciting a highly specific antibody 
response (Lafer et al, 1983a; Zarling et al. , 1984). Both 
polyclonal and monoclonal antibodies have been induced with 
several forms of Z-DNA (Stollar, 1986) . Some of the 
antibodies show selectivity for a particular base sequence, 
whereas others are more general anti Z-DNA antibodies (Lafer 
et al. , 1983a; Nordheim et al. , 1986). Polyclonal sera 
induced by brominated poly(dG-dC) fall in the later 
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category, while monoclonal antibodies from mice immunized 
with brominated poly(dG-dC), however, may have either kind 
of reactivity. One monoclonal antibody, Z-22 reacts with Z-
DNA of variable sequence, whereas another, Z-44, is 
selective for Z-DNA formed by (dG-dC) sequences, it does not 
react, for example, with poly (dG-dm^C) or poly (dT-dG) . 
poly(dC-dA) or other mixed base sequences in the Z-helical 
form (Nordheim et al., 1986). Antibodies against Z-DNA have 
served as probes in the search for naturally occurring left 
handed helix. Antibodies have identified Z-DNA sites in 
supercoiled plasmid and viral DNAs (Miller et al. , 1983; 
Nordheim and Rich, 1983; Hagen et al., 1985) and have served 
to titrate the transition from the B-form to Z-form as a 
function of superhelical density (Nordheim et al., 1982) or 
counterion or polyamine concentration (Thomas et al, 1988). 
They have also been used to identify and isolate Z-DNA 
regions from a library of E^ coli genomic DNA (Thomae et al, 
1983; Hoheisel and Pohl, 1987). A left handed Z-RNA has also 
been identified with poly (rG-rC) and corresponding 
antibodies have identified this structure in cytoplasm by 
immunofluorescence (Zarling et al., 1987). 
Possible Biological Role of Z-DNA 
The functional significance of the Z-DNA remains a 
provocative and controversial issue. Several observations, 
however, hint towards the possibility that left handed 
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motifs might be involved in the regulation of biological 
processes either directly by acting as potential templates 
for RNA polymerase (Sande and Jovin, 1982; Hipskind and 
Clarkson, 1983; Nordheim and Rich, 1983) and by modulating 
strand exchange (Fishel et al. , 1988) thus affecting 
transcription and recombination processes or indirectly by 
altering the extent of DNA packaging (Castleman et al., 
1984; Thomas and Bloomfeld, 1985; Reich et al, 1991) and 
supercoiling (Peck et al. , 1982; Rich et al. , 1984). The 
question that naturally arises is what physiological 
processes act in vivo to generate negative supercoiling that 
is continuously being removed by the activity of 
topoisomerase I (Zhang et al., 1988). Wittig et al.(1991) 
have suggested that transcription may be one of the 
physiological processes that generate negative supercoiling 
and this stabilizes Z-DNA formation in the intact cell. 
Conformational diversity of the DNA helix appears to be used 
quite extensively by living organisms with regard to 
protein- DNA recognition and hence function (Traverse, 
1989) . In several cases, DNA recognition by proteins seems 
to rely heavily, if not entirely, on DNA conformations and 
flexibility as opposed to base sequence per se (Otwinowski 
et al., 1988; Goodman and Nash 1989). 
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PolyaxDine-Nucleic Acid Interactions 
Polyamines are ubiquitous polycationic metaJbolites in 
prokaryotic and eukaryotic cells. Their roles in the 
regulation of major functions in cell growth, cell 
differentiation and their intricate and exquisitely 
regulated biosynthetic pathways have attracted considerable 
attention during the last few decades. Various books and 
reviews have dealt in length with these aspects, including 
the design of enzyme inhibitors which by depleting cells of 
their normal polyamine contents provoke cell growth arrest 
and other pharmacologically important phenomena (Heby, 1981; 
Pegg and Mc Cann, 1982; Tabor and Tabor, 1984; Pegg, 1986, 
1988; Mc Cann et al., 1987). Polyamines are found to be 
associated with ribosomes and membranes. Their precise 
function inside the cell is not fully understood. They are 
reported to have an antimutagenic effect and prevent 
dissociation of 70S ribosomes to SOS and 30S subunits. They 
increase the resistance of protoplasts to osmotic lysis. 
Polyamines stimulate translation (initiation and elongation) 
of the peptide chain and are implicated in maintaining 
translational fidelity, ribosome structure and stability 
(Marton and Morris, 1987) thus markedly influencing protein 
synthesis in both prokaryotes and eukaryotes. In various 
growing tissues, polyamine synthesis accompanies or precedes 
nucleic acid synthesis (Mc Cann et al., 1972, Heby et al. , 
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1976) . The increased synthesis of RNA also depends on the 
stimulating effect of polyamines on RNA polymerase. The 
concentration of polyamines is elevated in biological fluids 
and tissues in a number of disease states such as cancer, 
sickle cell anemia, cystic fibrosis, psoriasis and systemic 
lupus erythematosus (Puri et al. , 1978; Gunnia et al . , 
1991) . Similarly, the polyamine levels in the spleen cells 
of MRL-lpr/lpr mice are about three times higher than that 
in the spleen cells of normal mice (Bowlins et. al., 1986; 
Thomas and Messner, 1989). 
Spermine and spermidine are known to be widely 
distributed in nature. Spermine is the most abundant 
polyamine found in animal cells (Tabor and Tabor, 1984). 
Spermidine or spermine is essential for aerobic growth of 
Saccharomyces cerevisiae (Balasundaram et al., 1991). The 
amount of spermidine varies inversely with the amount of 
Mg in ribosomes, and 30S and 50S ribosomal subunits 
remain associated in the absence of Mg if spermine is 
present. 
Although the functions attributed to the polyamines are 
numerous, their modes of action at molecular level remain a 
matter of speculation. Because of their protonated amino 
groups (at physiological pH values), polyamines are known to 
bind to negatively charged cellular macromolecules such as 
nucleic acids. The interaction of polyamines with nucleic 
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acids may be responsible in part for the biological 
functions of polyamines (Basu et al., 1989). Association of 
polyamines with specific base sequences of nucleic acids has 
been found in crystals (Prinz et al., 1976; Quigley, 1982) 
and in solution (Igarashi et al. , 1977; Marton and 
Feuerstein, 1986; Basu et al, 1988). Thermophilic bacteria 
growing under extremes of heat are known to produce a 
variety of polyamines to protect their genetic material from 
denaturation (Oshima, 1982). The polyamines composition of 
the extreme thermophile depends on growth temperature 
(Oshima and Baba, 1981). The thermophilic cells grown at an 
optimum temperature (75°C) contain two novel tetramines, 
thermine (Oshima, 1975) and thermospermine (Oshima, 1979). 
Bordin et al. (1992) have suggested that different DNA 
superstructures are relevant in interactions with 
polycations, such as spermine. It has also been reported 
that spermine binds in the deep groove of the A-DNA octamer 
d(GTGTACAC) by interacting with the bases (Jain et al., 
1989) . Recent evidences indicate that polyamines play an 
important role in the growth of hormone responsive breast 
cancer (Kendra and Katzenellenbogen, 1987; Manni et al. , 
1992) . The interaction of polyamines with DNA produces 
profound changes in the structural organization and 
reactivity of DNA. These include, the stabilization of 
double stranded DNA, collapse of DNA into toroids and 
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s p h e r o i d s (Gosule and Schel lman, 1978; Thomas and 
Bloomfield , 1983) and the i n d u c t i o n of l e f t handed 
conformation in a l t e rna t i ng purine-pyrimidine sequences and 
plasmids containing blocks of these sequences (Behe and 
Felsenfeld, 1981; Thomas and Messner, 1988; Thomas et a l . , 
1991) . Polyamines have been shown to promote DNA 
aggregation, to s t a b i l i z e DNA agains t thermal denaturat ion, 
enzymatic degradation, and shear-induced s t r a i n , to induce 
the in vitro condensation of DNA, and to f a c i l i t a t e the 
t r a n s i t i o n of DNA from B-toZ-conformation (Vertino et a l , 
1987; F e u e r s t e i n and Marton, 1987) . I t has a l s o been 
sugges t ed t h a t polyamines may s t a b i l i z e c e r t a i n 
polynucleot ides , e .g . poly(dA-dT).poly(dA-dT) or poly(dG-
dC) .poly(dG-dC) , in a conformat ion which has reduced 
a f f i n i t y for e thidium bromide (Delcros e t a l . , 1993). A 
conformat iona l t r a n s i t i o n i s induced m poly (amino dA-
dT) .po ly(amino dA-dT) by micromolar c o n c e n t r a t i o n s of 
polyamines (30 i^M) in low s a l t aqueous s o l u t i o n . The 
r e s u l t i n g conformer i s suggested to be an A form (Garriga et 
a l . , 1993) . 
Natura l ly occurring polyamines have been reported to 
induce B to Z t r a n s i t i o n of poly(dG-m^dC).poly(dG-m^dC) at 
micromolar concentrations (Behe and Felsenfeld, 1981; Thomas 
et a l , 1985). Polyamine induced Z-DNA formation provides a 
p o t e n t i a l pathway for Z-DNA i n d u c t i o n and s t a b i l i z a t i o n 
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under physiologically relevant conditions. Thomas and 
Messner (1986) have shown that poly (dA-dC). poly(dG-dT) 
undergoes B to Z transition at low ionic concentrations in 
the presence of spermidine and spermine. This finding 
assumes significance because in contrast to the rare 
occurrence of blocks of (dG-dC) j^ . (dG-dC)j^  segments, blocks 
of (dA-dC)j^ . (dG-dT)j^  are widely dispersed in native DNAs 
(Hamada and Kakunaga, 1982; Hamada et al., 1982). 
Highly sensitive enzyme immunoassay techniques have 
demonstrated (Thomas et al., 1988) that, in the absence of 
polyamines, a polynucleotide sequence, poly(dG-
m^dC).poly(dG-m^dC) does not bind to monoclonal anti-Z-DNA 
antibody (Z 22) , but rapid interactions occur when 
polyamines are added to the system with gradual increase in 
concentration (Thomas and Messner, 1988). 
Klevan and Schumaker (1982) observed that addition of 
poly-L-arginine but not poly-L-lysine to poly(dG-
dC).poly(dG-dC) induces Z-conformation which is retained 
even after dialysis to low salt. This observation suggests 
that Z-DNA stabilization does not solely depend on simple 
electrostatic factors but may also involve some specificity 
in the interaction of arginine side chains with Z-helix. 
Analysis of interactions of HI and H5 histone with 
polynucleotides of B-and Z-conformations revealed two 
things. Firstly, at low protein:DNA ratios, both Hi and H5 
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bound more Z-DNA than B-DNA. Secondly, the binding of Z-DNA 
was less sensitive to interference by an increase in ionic 
strength (to 600 itiM NacD • Moreover, H5 histone caused more 
profound C D . spectral changes than did HI (Mura and 
Stollar, 1984) . These findings demonstrate the ability of 
different lysine" rich histones to cause varying 
conformational changes in the condensation of chromatin in 
DNA regions of highly biased base sequences. The occurrence 
of H5 is characteristic of cells which are inactive in both 
transcription and replication (Billet and Hindley, 1972; 
Urban et al., 1980). 
Recent studies have suggested that natural polyamines 
are capable of altering the immunogenicity of 
polynucleotides by mechanisms involving the stabilization of 
Z-DNA conformation (Gunnia et al., 1991). These results may 
have direct implications in the recent findings of high 
levels of polyamines and anti-Z-DNA antibodies in the sera 
of lupus patients and autoimmune mice, suggesting the 
involvement of polyamines in altering the topological state 
of DNA (Sehgal and Ali, 1990; Thomas et al., 1990). 
Autoismxinity and Autoimmiine Diseases 
The presence of antibodies in the sera of 
physiologically healthy individuals can be traced back to as 
early as 1900 when Landesteiner and his group reported the 
interaction of such antibodies with blood group determinants 
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of A-B-0 system. Subsequent studies have demonstrated the 
presence, in the sera of normal humans as well as that of 
several other animal species, of antibodies reacting with a 
variety of cellular and humoral constituents. These 
antibodies, subsequently termed natural antibodies were 
found, in some case, to react with self constituents, such 
as sperm, brain, and skin antigens, that under normal 
physiological conditions are not found in the circulation 
and therefore not exposed to the immune system. Natural 
antibodies are roughly of two types, one with a well defined 
and high specificity and another with a weak specificity. 
Boyden (1963) suggested that natural antibodies with well 
defined specificity may correspond to induced antibodies 
appearing after an antigenic stimulation, whereas natural 
antibodies with weak specificities may correspond to 
spontaneously appearing antibodies, i.e. those without the 
need for any known antigenic stimulus. In the 1960s, with 
the general acceptance of Burnet's clonal selection 
hypothesis, the studies on spontaneously occurring 
antibodies diminished considerably. This theory put forth 
the idea that there are lymphocytes which proliferate into 
antibody producing cell when they come in contact with a 
'non-self antigen. Lymphocytes capable of reacting with 
self components are deleted during embryonic life and 
provide self tolerance. On that basis, synthesis of 
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autoantibodies reacting with self components does not 
correspond to a physiological process but is the result of 
only pathological situations (Burnet, 1959). 
The function of the immune system is to discriminate 
between self and non-self. Normally, the immune system 
responds to a wide variety of foreign insults, such as 
bacteria, viruses, parasites, and internal changes such as 
cancer, while not responding to one's own self antigens. 
However, under varied stresses, the immune system fails to 
discriminate between *self' and 'alien', leading to antibody 
production against various cellular components. The term 
autoimmune disease, refers to a variety of illnesses in 
which immune processes are directed against the self. They 
may be predominantly humoral (antibody) or cellular in 
origin, or a combination of both. A hallmark of most 
autoimmune diseases is the presence of autoantibodies 
against self antigens. An autoimmune disease may be 
organ/tissue specific e.g. diabetes, autoimmune thyroiditis, 
Goodpasture's disease or primary biliary cirrhosis or non-
organ/tissue specific (systemic) such as progressive 
systemic sclerosis (PSS) or systemic lupus erythematosus 
(SLE) in scope. It may destroy, mimic, or enhance the 
target. It can range in severity, from being only an 
irritant to being fatal to the individual (Minard, 1989). 
The potential for autoimmunity is present in normal 
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individuals and each can become autoimmune under abnormal 
circumstances. Autoimmunity is prevented by proper immune 
regulation which is mediated by various T-lymphocyte sub-
populations. Helper and suppresser T-cells act together to 
establish an immunoregulatory balance, which determines the 
level of immune response to a particular antigen. A 
disequilibrium resulting either in the generation of helper 
T-cells, or in a deficiency of suppressor T-cells, could 
trigger potentially autoreactive B-cell clones to 
autoantibody production. Primary variations of the target 
organ can either be genetically determined changes of 
autoantigenic determinants or secondary alterations based on 
chemical, viral or other environmental factors. 
Possible Causes of Autoimmune Diseases 
Despite enormous knowledge accumulation about immune 
reactions, the etiology of autoimmunity is still an enigma. 
Based on various theories, the possible factors are 
discussed below. 
Immunorecnilation - The malregulation of the immune system 
depends on multiple components of the feedback regulation 
system including T cells, B cells, and idiotopes (Shoenfeld 
and Schwartz, 1984) . There are many components which have 
not been identified yet that can up or down-regulate cells 
of the immune system. Normally B-cells with potential to 
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produce autoantibodies are held in-check by a lack of helper 
cells or an abundance of suppressor cells. In autoimmunity, 
an imbalance of this regulatory system becomes manifest. 
Abnormalities of immune regulation in PSS due to an excess 
of helper cell function have been demonstrated (Krakauer et 
al, 1981), and diseases with depressed suppressor cell 
function, including SLE, diabetes mellitus, Graves'disease, 
multiple sclerosis (MS), myasthenia gravis (MG), RA, PSS, 
and primary biliary cirrhosis have been described (Shoenfeld 
and Schwartz, 1984) . In normal individuals, the T-helper to 
T-suppressor ratio is 2 : 1 in the peripheral blood, whereas 
in autoimmune diseases, this ratio shoots to 15:1 (Gray et 
al., 1987; Morimoto et al., 1987; Shivkumar et al., 1989). 
Because of complexity of the regulatory system, many factors 
can contribute towards an imbalance. Such an imbalance could 
be determined in part by the genetic make up and HLA types 
of the individual. The possibility of sporadic mutations in 
some individuals cannot be ruled out, though the mechanisms 
by which these mutations occur are not well understood. 
Various foreign organisms may upset the balance of 
immunoregulation. For example, HIV infection causes a switch 
from a Tjjl like lymphokine pattern to a Tjj2 type pattern. 
This switch is paralleled by an increased number of B cells 
and hypergammaglobulinemia, which is commonly seen in 
autoimmune diseases as well (Levinson, 1994) . 
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Tolerance- Tolerance is a state of immunologic 
nonresponsiveness to substances that would be expected to 
evoke an immune response, like one's own antigens. The 
impairment of self tolerance allows for autoimmune disease. 
Tolerance is accomplished through three mechanisms: thymic 
education, thymic deletion, and peripheral tolerance. Thymus 
is the major site for self-nonself discrimination. It is 
here that the T-cell repertoire is determined. Some cells 
are programmed to die (negative selection), while others are 
not (positive selection) (Adorini, 1993) . Those with a high 
affinity for self ligands are negatively selected. It has 
also been suggested (Rose, 1994) that thymus is the critical 
time keeper with ageing process with respect to immune 
responses. Because the thymus involutes asymmetrically, a 
clonal imbalance occurs with ageing, since the proportion of 
autoantigen-specific helper/inducer T cells increases as a 
function of autoantigen specific regulatory T cells. Thus, 
circulating autoantibody level rises with age. As the thymic 
cortex atrophies, the response to foreign antigens declines, 
whereas the response to self antigens rises, generating the 
ageing paradox. 
Viral factors- Viruses have close association with 
autoimmune diseases of humans and animals (Steinberg et al., 
1990; Kreig and Steinberg, 1990; Kreig et al., 1989; 1991). 
Viral infections can promote autoimmune reactions by varied 
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mechanisms. It is conceivable that infectious antigens could 
cause an immune response aimed towards destroying the 
infectious agent that could lead to cellular damage and 
autoimmune disease. Molecular machinery can be another 
factor responsible for autoimmune reactions as a result of 
viral infection. In such a case, there is similarity between 
stretches of amino acid or other sequences in molecules of 
the infectious organisms and molecules of the host, e.g. 
adenovirus type 2 has sequences very much like those of 
myelin basic protein (Steinman, 1993). In responding to the 
virus, the immune system may generate antibody response 
against the self molecule. 
Epstein-Barr virus (EBV) has been most prominently 
considered as a cause of autoimmune disease because of its 
ubiquity, persistence and ability to act on the immune 
system. For example, EBV acts as a polyclonal B cell 
activator, stimulating mitosis and immunoglobulin secretion 
as well as promoting autoantibody production, especially 
rheumatoid factor (Gregory et al., 1991). 
Genetic factors- Autoimmune diseases, in general, show a 
highly significant familial predisposition. Relatives of a 
patient suffering from autoimmune disease are at high risk 
of developing similar autoantibodies as compared to general 
population (Arnett and Shulman, 1976; Hochberg, 1987; 
Arnett, 1992) . The majority of the genes which have been 
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associated with autoimmune diseases, map within the MHC of 
man, or HLA region. The MHC comprises of three functionally 
and polymorphic gene classes: classes I, II and III. Most of 
the MHC associations with SLE, the prototype of autoimmune 
diseases, involve class II (HLA-DR and DQ alleles) and class 
III alleles, especially null or deficiency alleles of the 
fourth component (C4) of complement (Bias et al. , 1986,-
Goldstein and Arnett, 1987; Braun and Zachary, 1988; Arnett 
and Moulds, 1991; Deodhar, 1992). 
Role of B-lymphocytes- Polyclonal B cell activation has been 
proposed as one possible mechanism that may be responsible 
for over activation of B-cells and production of 
autoantibodies in certain autoimmune disease, particularly 
SLE (Klinman et al. , 1990; Steinberg et al. , 1990; 
Steinberg, 1992). B lymphocytes are normally subjected to 
heavy and ongoing selection through their antigen specific 
Ig receptors. B-cell tolerance can be mediated by multiple 
mechanisms. Tolerance can lead to cell death or editing of 
antigen-receptor genes. Defects in B-cell tolerance may play 
a role in, or cause systemic autoimmunity (Nemazee, 1993) . 
Zouali (1994) has proposed that hyperproduction of lupus 
associated autoantibodies arises through a two stage 
mechanism whereby a general activation of the multireactive 
preimmune B-cell repertoire precedes oligoclonal expansion 
of selected B-cell clonotypes. It has also been indicated 
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that precursor B cells for IgG anti-dS DNA response in SLE 
patients are similarly selected and expanded, as are 
precursor B-cells specific for any foreign antigen, which 
implies that IgG anti-ds DNA response in SLE patients is 
antigen driven (Schwab et al., 1994) . 
Systemic Lupus Erythematosus 
Systemic lupus erythematosus (SLE) is a prototype human 
autoimmune disease that manifests itself with a variety of 
fascinating clinical and immunological features. Although 
the causes of SLE and autoimmunity in general, remain 
unknown, considerable evidence has accrued on the 
pathophysiologic mechanisms that lead to the failure of 
distinction between self and non-self. Various factors that 
could either directly or indirectly be involved in the 
etiology of autoimmunity have been suggested (Tsokos, 1992) 
and are given below -
Factors 
Genetic 
Immune 
Hormonal 
Mediators 
Autoantibodies 
Immune complexes 
Complement activation 
Tissue 
destruction 
Environmental 
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SLE is a multisystem inflammatory disease characterized 
by diverse ANA specificities. In patients with this disorder 
ANA production is almost invariable; over 95% of patients 
have a positive fluorescent antinuclear antibody (FANA) test 
(Pisetsky, 1994) . Table 2 lists common ANA specificities 
found in lupus, designating the frequency of the antibody 
and the structure and function of the antigens. These 
specificities can be divided into two groups- those unique 
to SLE and those found in other rheumatic diseases. Only 
anti-DNA and anti-Sm are unique to SLE and serve as criteria 
in disease classification. Despite the presence of 
antibodies to both ss and ds DNA, most clinical assays are 
designed to detect antibodies to ds DNA because of increased 
specificity for diagnosis (Pisetsky, 1993). 
Anti-DNA antibodies are the most prominent serological 
abnormality of SLE and occur in patients as well as 
spontaneous animal models of lupus. The presence of anti-DNA 
antibodies in the serum of SLE patients has long been 
considered both as marker of, and pathologic factor in renal 
disease (Andres et al., 1970; Koffler et al. , 1974). There 
are reports of serum anti-ds DNA antibody levels correlating 
with the severity of the renal disease in SLE (Wallace et 
al., 1993). Recently Okamura et al (1993) have shown a 
strong correlation between anti-ds DNA IgG levels and renal 
histology that was not evident for anti-ds DNA IgM or for 
31 
TABLE 2 
Princ ipal Antinuclear Antibodies 
Erythematosus 
in Systemic Lupus 
S p e c i f i c i t y Target Antigen Function Frequency 
in SLE 
(%) 
Native DNA dsDNA 
Denatured DNA ssDNA 
Histones Hi,H2A,H2B,H3,H4 
Sm snRNP proteins 
B,B',D,E 
UlRNP SnRNP proteins 
A,C,70K 
SS-AR/Ro 60-kd and 52-kd 
protein,complexed 
SS-B/La 
Ku 
PCNA/cyclin 
Genetic information 
Genetic information 
Nucleosome structure 
Splicesome component, 
RNA processing 
Splicesome component, 
RNA processing 
Unknown 
with Y1-Y5 RNA 
46-kd protein comp- Regulation of RNA 
lexed with various polymerase 3 transcript-
RNA 
86-kd and 66-kd 
proteins 
36-kd protein 
40 
70 
70 
30 
32 
35 
15 
Ribosomal RNP 38-kd,16-kd,and 
15-kd phosphoprot-
eins,associated with 
ribosomes 
Source : Tan, E.M. (1989) 
ion 
DNA binding 3 
Auxiliary protein of DNA 10 
polymerase 
Protein synthesis 10 
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anti-single stranded DNA (anti ssDNA) antibodies of either 
isotype. Various serological findings suggest that lupus 
nephritis results from the deposition of DNA-anti-DNA 
complexes and subsequent complement mediated tissue damage 
(Emlen et al., 1986; Pisetsky, 1992). 
It is evident that the development of antibodies per se 
even anti-DNA antibodies, does not automatically lead to 
autoimmune disease. Healthy individuals, notably, the 
elderly and especially relatives of patients with autoimmune 
disease may develop a range of autoantibodies without any 
adverse effect (Shoenfeld and Isenberg, 1989). This 
observation must be viewed in the context of anti-DNA 
antibodies. While, 20-30% of the healthy relatives of SLE 
patients demonstrate the presence of antibodies against 
single stranded DNA (Miles and Isenberg, 1993), antibodies 
to double stranded, or native, DNA virtually never occur in 
these relatives. Thus antibodies to ds DNA do seem to be 
particularly associated with SLE. 
The question of a direct role of anti-ds DNA antibodies 
in the pathogenesis of murine lupus has been reexamined 
recently. Vlahakos et al. (1992a) have described the ability 
of murine monoclonal anti-ds DNA antibodies (derived from 
MRL/lpr and SNFl lupus prone mouse strains) injected into 
healthy-strain mice to form immune deposits at distinct 
glomerular and vascular sites. Taking lead from the work of 
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Shmiedeke et al. (1989), who showed that histones can bind 
with high affinity to glomerular basement membrane (GBM), 
Brinkman et al. (1990) and Termaat et al. (1992) have 
reported that anti-DNA antibodies bind to glomerulus via 
complexes of histones and DNA and, to a lesser extent via 
DNA alone. In another study, Vlahakos et al. (1992b) have 
provided evidence that murine monoclonal antibodies were 
able, in vivo, to penetrate cells and interfere sufficiently 
with their normal function as to contribute to their 
pathologic abnormalities. However, a very small percentage 
(5 out of 30) of these antibodies were able to do this, 
which suggests that direct anti-DNA antibody penetration is 
unlikely to be a significant pathologic process in SLE 
patients. The question of antibody penetration now goes back 
to some 15 years (Alarcon et al., 1978), since the original 
suggestion that anti-RNP antibodies might possess this 
ability. However, with rare exceptions (Okudaira et al., 
1987), no other group has convincingly described this 
phenomenon. Recent studies have again reiterated direct 
association between anti-RNP autoantibodies and severity of 
lupus nephritis (Guialis et al., 1994; Reichlin et al., 
1994) . 
In other studies of murine lupus, IgM anti-ssDNA 
antibody derived genes have been expressed in healthy 
strains of mice (Erikson et al., 1991). It was shown that 
34 
although many B-cells in these animals were able to express 
anti-DNA immunoglobulin on their surface, the cells were 
anergic-perhaps as a result of having been exposed to 
antigen. The healthy strain mice were able to control these 
potentially disease associated antibodies. Tsao et al (1992) 
have described another transgenic model utilising H and L 
chain genes from a hybridoma secreting an IgG monoclonal 
anti-DNA antibody. Many of the B-lymphocytes in this 
transgenic model expressed endogenous IgM and some expressed 
low levels of transgene-derived IgG, on cell membrane. As in 
the initial model, the transgenic animals did not develop 
major manifestations of lupus. However, these animals were 
found to have elevated levels of IgG anti-DNA antibodies in 
their serum and a minor degree of nephritis was noted. 
Interestingly, immunizing these animals with DNA increased 
the anti-DNA levels. 
These results fall short of explaining the origins of 
human lupus in general or anti-ds DNA antibodies in 
particular. Three main concepts on the origin of human lupus 
have emerged from various experiments performed on 
genetically predisposed models. The first concept proposes 
that systemic autoimmune disease is the result of polyclonal 
B-cell activation (Klinman and Steinberg, 1987) , The second 
suggests that autoreactive clones are the result of antigen-
driven specific stimulation (Hardin, 1986). The third 
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envisages a two stage development, incorporating elements of 
both polyclonal activation and an antigen driven response 
(Zouali, 1992). Based on evidence available from human 
studies, the third view is considered to be the most valid 
explanation (Isenberg et al., 1994). 
Mammalian DNA is non-immunogenic in a variety of animal 
species tested (Schwartz and Stollar,1985) . However, 
sequence analysis of anti-DNA antibodies shows features of 
antigenic selection. In contrast to mammalian DNA, bacterial 
DNA can induce a good antibody response (Gilkeson et al. , 
1989) . It has been noted that anti-DNA antibodies may be 
very similar in structure to anti-bacterial antibodies (Hahn 
and Tsao, 1993) . This suggests that anti-dsDNA might arise 
from stimulation with foreign, rather than self DNA. 
Recently, Krishnan and Marion (1993) have shown that 
monoclonals, though a small number, generated against a 
complex of native DNA and a synthetic DNA binding protein 
shared DNA specificities and V region structures with anti-
DNA monoclonals derived from lupus prone NZB/NZW mice. 
Another possible explanation for the presence of these 
antibodies is that DNA linked to histones, abundantly found 
in nucleosomes may be a stimulating antigen (Ehrenstein et 
al., 1993) . 
It has also been suggested that activated phagocytic 
cells can release highly reactive oxygen species (ROS) which 
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can penetrate cell membranes, interact with nuclear DNA and 
cause the release of altered DNA, which in turn, could 
stimulate anti-DNA antibodies (Gordon et al., 1990; Alam et 
al., 1993) . 
Anti-DNA antibodies are polyspecific showing enormous 
cross-reactivity. The nature of epitopes that are bound by 
anti-DNA antibodies is only partially elucidated. A range of 
specificities is attributed to these immunoglobulins. 
Monoclonal antibodies and sera from SLE patients and lupus 
prone animal models show that reactivity may be greater 
towards denatured forms of DNA (Stollar et al., 1986). Anti-
DNA antibodies may react directly with nucleosides and 
nucleotides, with some antibodies exhibiting marked 
preference for particular bases/base pairs. Thus reactivity 
with poly (dA-dT), poly{dG-dC), poly (dA), poly{dT), poly 
(d[BrU]) has been reported (Tron et al, 1980; Gripenberg et 
al, 1981; Hahn and Ebling, 1984; Gibson et al, 1985; Stollar 
et al., 1986). Poly (ADP-ribose), a polymer that is produced 
in response to certain forms of DNA damage has also been 
reported for reactivity with anti-DNA antibodies (Dudeney et 
al, 1986) . Additional specificities include other forms such 
as ssRNA, dsRNA, triple helical RNA, RNA-DNA hybrids 
(Karounos et al, 1988) . SLE autoantibodies have also been 
reported to recognize multiple conformations of DNA, e.g. 
left handed DNA (Z-form), DNA-psoralen photoadduct, DNA-
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lysine photoadduct, hydroxyl radical modified DNA, DNA-8-
methoxypsoralen photoadduct, estradiol-albumin-DNA conjugate 
(Sehgal and Ali, 1990; Hasan and Ali; 1990; Ali et al., 
1991; Hasan et al., 1991; Alam and Ali, 1992; Alam et al., 
1992; Ara et al., 1992; Ara and Ali, 1992; 1993; Arjumand 
and Ali, 1994; Moinuddin and Ali, 1994). Arif et al. (1994) 
have reported human autoantibody binding with polylysine-
polyglutamate complex. Given that anti-DNA antibodies may 
exhibit polyreactivity, it is believed that at least some of 
the epitopes bound by these autoantibodies must be present 
in sugar phosphate backbone common to all polynucleotides 
(Alam et al., 1995). 
Role of Steroids in SLE 
The basic question on the origin of anti-DNA antibodies 
in autoimmune diseases like systemic lupus erythematosus 
(SLE) has not been answered until now. SLE is a chronic 
debilitating disease which primarily affects women of child-
bearing age. A role for estrogens in the pathogenesis of SLE 
has long been suspected (Rose & Pittsbury, 1944; Tumulty, 
1954; Chapel & Burns, 1971; Fine et al, 1981) . DNA against 
which most of the antibodies are detected in SLE and other 
autoimmune diseases is no longer regarded as the antigen 
initiating the disease because immunization with DNA does 
not induce disease like SLE. Female predominance of SLE is 
well documented but the mechanism(s) by which estrogen 
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exerts its effects on autoimmune diseases is not clearly 
elucidated. Recently, it has been shown that estrogen 
augments autoantibody formation in normal mice by a direct 
stimulatory effect on CDS"*" B cells, known to be responsible 
for autoantibody production (Ahmad et al, 1989). 
Epidemiological studies (Masi and Medsgar, 1979) have shown 
an incidence of SLE in black women of approximately 1:250 
and 1:2000 overall. SLE is nine times more common in women 
and fifteen times more common during child bearing years. 
Peak onset is between 16 and 25 years of age. The 
predominance of females among patients with systemic lupus 
erythematosus (SLE) and frecjuent exacerbation of disease 
during pregnancy (Jungers et al, 1982a) or following oral 
contraceptive therapy (Jungers et al, 1982b) strongly 
suggest that sex hormones influence disease activity. 
Patients with Kleinfelter's syndrome, i.e. males with 47 
chromosomes are hyperestrogenic and have an increased 
incidence of SLE (Stern et al, 1977) . Recent studies have 
revealed an abnormal pattern of estrogen metabolism among 
SLE patients. It has also been reported that an excessive 
level of testosterone oxidation at the C17 level is present 
in female SLE patients compared with normal women (Lahita et 
al, 1983). Plasma androgen levels have been found to be 
normal in male SLE patients (Stahl and Decker, 1978). 
However, a significant reduction in all plasma androgen 
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levels has been observed in SLE patients (Jungers et al, 
1982c) either in acute phase of disease prior to any 
corticosteroid therapy or after therapeutic remission. Low 
plasma testosterone levels in women with SLE have also been 
confirmed (Lahita et al, 1983). 
The ability of sex hormones to modulate murine lupus 
was revealed more than 10 years ago when Talal and his 
colleagues reported that castration of male NZB/NZW (B/W) 
mice eliminated a protective factor and resulted in enhanced 
autoimmune disease expression and death (Roubinian et al, 
1977) . It was then demonstrated by implanting 5-oC-
dihydroxytestosterone (DHT) in female B/W mice that the 
protective factor was male hormone (Roubinian et al, 1978). 
A significant therapeutic effect could be achieved even if 
DHT treatment was delayed until six months of age (Roubinian 
et al, 1979) when female B/W mice were already dying of SLE. 
These experiments demonstrated that, female sex hormones 
accelerate autoimmunity, whereas male sex hormones suppress 
it. It is now known that sex hormones modulate the normal 
immune response and therefore, their immunologic effects are 
physiological (Ahmad et al, 1985; Ahmad and Talal, 1988). In 
(NZB/NZW) Fl (NZB/W) mice, a murine model for human SLE, 
females develop an earlier and more severe disease compared 
to males (Howie and Helyer, 1968). In several studies it has 
been suggested that estrogen is an accelerator of the lupus 
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disease of NZB/W mice whereas testosterone has protective 
properties (Roubinian et al, 1978; Steinberg et al, 1979; 
Siiteri et al, 1980). Also, MRL Ipr/lpr (MRL/l) mice, 
spontaneously developing a rapidly progressive autoimmune 
disease, constitute a model for human SLE. Immune complex 
mediated glomerulonephritis, massive lymph node 
proliferation, vasculitis, arthritis and production of a 
variety of autoantibodies are some hallmarks of lupus 
disease in MRL/l mice (Andrews et al, 1978; Theofilopoulos 
and Dixon, 1981) . The mean life span of male and female 
MRL/l mice is 5.1 and 4 months respectively (Murphy and 
Roths, 1978). Steinberg et al (1980) demonstrated that 
administration of testosterone to MRL/l mice resulted in a 
less severe disease. 
SLE patients, as well as B/W mice, demonstrate a 
delayed clearance of particulate immune complexes. Female 
B/W mice exhibit this abnormality earlier than males. 
Furthermore, androgens suppress this defect in female mice. 
Estrogens, in contrast, accelerate this defect in male B/W 
mice. This suggests an important influence of sex steroid 
hormones on the clearance of immune complexes (Ahmad et al, 
1985) . 
Antibodies against steroids have been raised by 
immunizing mice with the ligand conjugated steroids. 
Monoclonal antibody production against proteinic and steroid 
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hormones has also been reported (Kohler and Milstein, 1975). 
The feasibility of generating monoclonal antibodies against 
progesterone (P^) and their characteristics have also been 
reported (Fantl et al, 1981; 1982; Wright et al, 1982; White 
et al, 1982; Fantl and Wang, 1984; Gupta et al, 1987). 
Antihormonal and antinuclear (ANA) responses have been 
reported by Sarah and colleagues (1987) from a population of 
female mice immunized with estradiol-albumin. 
The target tissues for various classes of steroid 
hormones contain characteristic extranuclear "receptor" 
proteins which combine with the hormone and accompany it to 
its site of localization in the cell nucleus. Sex hormones 
can influence the immune system through multiple pathways. 
They bring about their effect on target cells by first 
interacting with specific steroid receptors. Sex-hormone 
receptors have been found not only in classical reproductive 
tissues but also in diverse unrelated body systems, 
including the immune system. The presence of sex hormone 
receptors in these non-classical sites may indirectly have a 
relevance to the immune system (Talal and Ahmad, 1987) . 
Sex hormones have specific effects on lymphocytes. It 
appears that T cells are primary targets of sex-hormone 
action (Ahmad et al, 1985; Ahmad and Talal, 1987). 
Regulatory T-cells appear to be more sensitive to sex-
hormones. In humans, estrogen receptors have been 
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demonstrated on OKT-8 positive cells of peripheral blood 
which have supressor/cytotoxic activity. All the cells 
closely associated with lymphocytes which are important in 
the functioning of the immune system bear sex hormonal 
receptors. For example, sex-hormone receptors are present on 
the thymic epithelial cells (Ahmad et al, 1985). It has long 
been argued that thymus is the primary lymphoid gland 
through which sex hormones influence the immune responses. 
Sex hormones may interact with thymic epithelial cells to 
alter the thymic microenvironment and the release of thymic 
hormones which in turn profoundly influence the immune 
system (Talal & Ahmad, 1987). 
Objective of the Present Study 
The polyspecific nature of anti-DNA antibodies and the 
non-immunogenecity of native DNA (B-conformation) poses a 
puzzling question regarding the origin of these antibodies. 
Elevated levels of anti-DNA antibodies are found in active 
lupus and represent serological markers for diagnosis and 
prognosis. SLE is a chronic syndrome that primarily affects 
women, pointing towards the possible role of sex hormones in 
disease etiology. In this study two aspects were probed; 
One, the possibility of Z-DNA being the immunogenic trigger 
for the production of anti-DNA antibodies in SLE and second, 
the possible involvement of female sex hormone in lupus 
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etiopathogenesis. Z conformation was induced in native DNA 
as a result of bromination in high salt and interaction with 
polyamines. Small size DNA fragment was covalently linked to 
estradiol-albumin to see whether the female sex hormone 
(estradiol) in conjugation with DNA could form a possible 
antigenic trigger for SLE and whether this conjugate would 
be recognized by naturally occurring SLE anti-DNA 
antibodies. 
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A. MATERIALS 
Chemicals 
Calf thymus DNA, bovine serum albumin, estradiol-
albumin, S-estradiol, xylene cyanol FF, ethidium bromide, 
anti-human and anti-rabbit IgG alkaline phosphatase 
conjugate, Freund's complete and incomplete adjuvants, 
coomassie Brilliant Blue G250 & R250, dialysis tubing (of 
varying diameter), poly-L-glutamic acid, poly-D-lysine, 
poly-L-lysine, spermine, spermidine, putrescine, millipore 
filter (0.45)um pore size), nuclease SI and 4-methyl 
umbelliferyl phosphate were purchased from Sigma Chemical 
Company, U.S.A. Dextran Blue 2000, DEAE Sephacel, Sephadex 
G-200, Sepharose 4B, protein A-Sepharose CL-4B, agarose 
(NA) , micrococcal nuclease, poly(dG-dC) .poly(dG-dC), 
poly (rG) .poly (dC) , were the products of Pharmacia Fine 
Chemicals, Sweden. Acrylamide, ammonium persulfate, 
bisacrylamide, N,N,N\N'-tetraethyl methylene diamine and 
Tween 20 were obtained from Bio-Rad, U.S.A. Perchloric acid 
and sodium azide were from Ferak-Berlin, Germany. 
Acetaldehyde was a product by Fluka, Switzerland. 
p-nitrophenyl phosphate and Folin-ciocalteu reagent were 
purchased from Centre for Biochemical Technology, New Delhi. 
ELISA plates were from Nunc, Denmark and Dynatech, U.S.A. 
All other chemicals were of highest purity analytical grade 
procured from reputed Indian firms like, Qualigens, B.D.H. 
and Merck. 
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Equipment 
Bausch and Lotnb spectronic 20, Shimadzu UV-240 
spectrophotometer equipped with a thermoprogrammer and 
controller, Shimadzu spectrofluorophotometer RF-540, ELISA 
Reader MR600 (Dynatech, USA), Jasco J-720 spectro-
polarimeter, cooling centrifuge C-24 (Remi, India), 
Horizontal gel electrophoresis assembly GNA-100 (Pharmacia, 
Sweden) , desk top microfuge RM-12C (Remi, India) and UV-
fluorescent table TF-20M (Vilber Lourmat, France) were the 
major equipments used in this study. 
Collection of Sera 
The normal human sera were collected from healthy 
subjects without evidence of SLE or other autoimmune 
disorders. Sera of patients with systemic lupus 
erythematosus (SLE) were obtained from the patients admitted 
to the Medical College Hospital of A.M.U. and from the 
patients at the outdoor Medicine clinic of A.I.I.M.S., New 
Delhi. The SLE sera were obtained from the patients who had 
elevated levels of anti-DNA antibodies and met the revised 
criteria for the American Rheumatism Association (ARA) for 
the diagnosis of the disease (Tan et al, 1982) . All serum 
samples were heat decomplemented at SS^C for 30 min. After 
decomplementation, the sera were stored at -20°C with 0.02 
percent sodium azide as preservative. 
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B. METHODS 
Purification of DNA 
Connnercially available, highly polymerized calf thymus 
DNA was purified free of proteins and single stranded 
regions (Ali et al, 1985). Solutions of DNA (2 mg/ml) in 0.1 
SSC buffer (0.015 M Na-citrate, 0.15 M sodium chloride, pH 
7.3) were mixed with equal volume of chloroform-isoamyl 
alcohol (24:1) in a stoppered measuring cylinder and shaken 
gently for 1 hr. The DNA present in the aqueous layer was 
separated from organic layer and again subjected to 
extraction. After extraction the DNA was precipitated with 
two volumes of cold 95% ethanol and collected on a glass 
rod. It was dried by pressing against the wall of the 
container. The DNA was dissolved in 30mM acetate buffer, pH 
5.0 containing 30mM zinc chloride. The single stranded 
regions that might be present in the DNA were removed by 
treatment with nuclease SI (200 units/mg of DNA at 37°C for 
30 minutes). The reaction was terminated by adding one-tenth 
volume of 0.2 M EDTA pH 8.0. The purified DNA was extracted 
twice with chloroform-isoamyl alcohol and reprecipitated 
with cold 95% ethanol. The DNA precipitate was dried and 
dissolved in the required buffer. 
DNA Estimation by Burton Method 
Colorimetric estimation of DNA was carried out 
according to Burton (1956) using diphenylamine. 
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Diphenyleunine reagent 
The reagent was prepared itnmediately before use by 
dissolving 750 mg of recrystallized diphenylatnine in 50 ml 
of glacial acetic acid containing 0.75 ml of concentrated 
sulphuric acid. 
Assay procedure 
Varying amount of DNA in 1.0 ml was mixed with 1 N 
perchloric acid and incubated at 70°C in a water bath for 15 
minutes. One hundred i^l of 5.43 mM acetaldehyde was added 
followed by 2.0 ml of diphenylamine reagent. The tubes were 
vortexed and allowed to stand at room temperature for 16-20 
hr for color development. Absorbance was recorded at 600 nm. 
The DNA concentration in the unknown sample was determined 
from the standard plot of purified calf thymus DNA (Fig. 1). 
Estimation of Protein 
Protein was estimated by the method of Lowry et al. 
(1951) and Bradford (1976). 
Protein Estimation by Polins-Phenol Reagent 
This method of protein estimation utilizes alkali (to 
maintain high pH) , Cu^ "^  ions (to chelate proteins) and 
tartarate (to keep the Cu^ "^  ions at high pH) . 
(a) Folin-ciocalteu reagent 
The reagent was purchased from Centre for Biochemical 
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Technology, New Delhi (India). It was diluted with distilled 
water in the ratio of 1:4 before use. 
(b) Alkaline copper reagent 
The components of alkaline copper reagent were 
(i) Two percent sodium carbonate in 0.1 M sodium 
hydroxide. 
(ii) 0.5 percent copper sulphate in 1.0 percent sodium 
potassium tartarate. 
The working reagent was prepared afresh by mixing 
components (i) and (ii) in the ratio of 50:1. 
(c) Procedure 
To 1.0 ml of protein sample was added 5.0 ml of 
alkaline copper reagent, the contents were mixed and left at 
room temperature for 10 minutes. Then 1.0 ml of Folin-
ciocalteu reagent was added and after 30 minutes the 
absorbance was monitored at 660 nm. The protein content of 
unknown samples was determined from a standard plot of 
bovine serum albumin (Fig. 1 ) . 
Protein Estimation by Bradford Method 
This colorimetric assay is performed under acidic 
condition. The color change occurs when coomassie Brilliant 
Blue G250 binds strongly to protein hydrophobically and at 
positively charged groups. In the environment of these 
positively charged groups, protonation is suppressed and a 
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blue color is observed ( A max = 596 nm). 
(a) Dye preparation 
One hundred milligram of coomassie Brilliant Blue G 250 
was dissolved thoroughly in 50 ml of 95% ethanol. To this 
solution was added 100 ml of 85% (v/v) orthophosphoric acid. 
The resulting solution was diluted to a final volume of 1 
liter. It was filtered before use. 
(b) Protein assay 
Solution containing 10-100 jug protein in a volume of 
upto 0.1 ml was pipetted into test tubes. The volume was 
adjusted to 1.0 ml with appropriate buffer. Five milliliter 
of dye solution was added and the contents were mixed by 
vortexing. The absorbance was read at 595 nm within an hour 
against a reagent blank prepared from 0.1 ml of buffer and 
5.0 ml of dye solution. 
Micrococcal Nuclease Digestion of Native Calf Thymus DNA 
Purified calf thymus DNA (2 mg/ml) in 0.006 M Tris, 0.1 
M sodium chloride, 0.002 M calcium chloride, pH 8.0 was 
digested with micrococcal nuclease (40 units/mg DNA) for 3.0 
minutes at 37"C. The reaction was stopped by adding one-
tenth volume of 0.2 M EDTA, pH 8.0. The sample, after 
precipitation with double distilled cold ethanol, was 
subjected to nuclease SI digestion (200 units/mg DNA) for 30 
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Fig.2. Elution profile of micrococcal nuclease 
digested native calf thymus DNA on Sepharose 
4B gel-filtration column. 
Inset: Polyacrylamide slab gel electrophoresis 
pattern of alternate fractions from 22 to 38 
alongwith EcoRI and Hind III digested Lambda 
DNA as marker. 
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minutes at 37°C (Ali et al, 1985). The sample was extracted 
twice with chloroform-isoamyl alcohol and reprecipitated 
with cold ethanol. It was dissolved in TBS (O.OIM Tris, 0.15 
M sodium chloride, pH 8.0) and passed through a sepharose 4B 
column (2cm x 44cm) previously equilibrated with the same 
buffer. Fractions of 4.0 ml were collected and monitored for 
DNA content at 260 nm, using 1.0 O.D at 260 nm =50 ^g ds 
DNA/ml (Fig. 2). The size of the DNA fragments was analyzed 
by polyacrylamide gel electrophoresis without stacking gel 
using lambda DNA digest of Eco RI and Hind III as size 
marker. 
Modification of DNA 
(a) Bromination of DNA 
Purified native calf thymus DNA was brominated under 
high and low salt conditions as described by Lafer et al 
(1981). High purity distilled water was saturated with 
liquid bromine. Native DNA was treated for 1 hr with 4 M 
NaCl in citrate buffer (0.02M sodium citrate, pH 7.2 
containing 0.001 M EDTA) and used at a final concentration 
of 100 ;ag/ml. The same amount of DNA in PBS (0.01 M 
phosphate buffer, pH 7.4 containing 0.15 M NaCl) served as 
low salt control sample. The bromine water was added to DNA 
in 1:4 ratio and kept at room temperature for 30 minutes. 
After bromination, the samples were extensively dialysed 
against TBS, pH 7.4 to remove excess bromine. Native DNA, 
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brotninated in high and low salt solutions were designated as 
Br4 and BrN respectively. Absorbance value of native and 
brotninated DNA was recorded at 260, 280, 294 and 296 nm 
against TBS, pH 7.4. The average of absorbance at 294 and 
296 nm divided by absorbance at 260 nm was termed as 
"absorbance ratio". The UV absorption spectra of low and 
high salt brominated DNA were recorded against buffer (TBS, 
7.4) and compared with the control spectrum obtained with 
same concentration of DNA solution. While recording the UV 
difference spectra of Br-native DNA, the same concentration 
of native DNA served as control. The native and brominated 
DNA were also subjected to circular dichroism measurements. 
The baseline of the instrument was adjusted with the buffer. 
(b) DNA- Polyeu&ine interaction 
Purified calf thymus DNA was first dialyzed against 
cacodylate buffer (0.001 M sodium cacodylate, 0.05 M NaCl, 
0.00015 M EDTA, pH 7.4). The nucleic acid was then taken 
into cacodylate buffer but without EDTA. Stock polyamines 
solution were also prepared in the same buffer. The DNA was 
mixed with varying concentrations of different polyamines 
and incubated for 30 minutes at room temperature. Double 
stranded poly.(dG-dC) was also complexed with polyamine in 
the similar fashion. Solutions of nucleic acids without 
polyamine formed the control sample. For each concentration 
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of polyamines, triplicate sets of polyamine- nucleic acid 
were prepared. 
(c) Preparation of DNA-B5A conjugates 
Glutaraldehyde, a bifunctional cross linking reagent 
that links two compounds primarily through their amino 
groups was used for coupling DNA to BSA using the single 
step method of Reichlin (1980) with a slight modification. 
To 1.0 ml solution of fractionated DNA (average size 200 bp) 
from a stock of 1 mg/ml in PBS, pH 7.2 was added 30 i^L of 
BSA from a 100 mg/ml stock in PBS. Then 1 ml of 0.2 % 
glutaraldehyde solution was slowly added with constant 
shaking and the mixture was incubated at room temperature 
for 1 hr. The reaction was stopped by adding glycine (in 
PBS, pH 7.2) to a final concentration of 200 mM followed by 
stirring for 1 hr at room temperature. The separation from 
unlinked constituents was achieved by gel exclusion on 
Sephadex G-200. 
(d) Preparation of Estradiol-Albumin-DNA (E2-BSA-DNA) 
conjugates 
One milliliter solution of DNA ( 1 mg/ml stock in PBS, 
pH 7.2) was mixed with 3.0 ml of estradiol-albumin solution, 
(1 mg/ml in physiological saline) . The contents were air-
dried to 2.0 ml and 2.0 ml of 0.2 % glutaraldehyde solution 
was added and the mixture was left at room temperature for l 
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hr. The reaction was stopped by adding glycine (in PBS, pH 
7.2) to a final concentration of 200 mM. The separation of 
linked conjugates from unlinked entities was achieved by gel 
filtration on sephadex G-200. 
Separation of Linked Conjugates (DNA-BSA and E2-BSA-DNA) 
From Unlinked Constituents 
The separation was achieved by gel filtration on a 
Sephadex G-200 column (46 cm x 1.0cm) previously 
equilibrated with PBS, pH 7.2. Just after the completion of 
the reaction, the sample was loaded on the column and eluted 
with the equilibrating buffer. Fractions of 2.5 ml were 
collected and the amount of DNA and protein in each 
fraction was determined by the method of Burton and Lowry et 
al. respectively. Fractions containing both DNA and protein 
were pooled together and taken as DNA-BSA and E2-BSA-DNA 
conjugates. These fractions were characterized by 
ultraviolet spectroscopy. 
Absorption-Teo^erature Scan 
Native and modified DNA samples were subjected to heat 
denaturation by an electronically controlled heating device 
(Hasan and Ali, 1990). All the samples were melted from 30°C 
to 95''C at a rate of 1.0°C/min after 10 minutes 
equilibration at 30°C. The change in absorbance at 260 nm 
was recorded with increasing temperature. Percent 
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denaturation was calculated using the following equation. 
AT-A30 
Percent denaturation = x 100 
AF-A30 
Where, 
A^ is the sample absorbance at a temperature T°C. 
Ap is the final absorbance at 95"C. 
A3Q is the initial absorbance at 30°C. 
Thenaodynamic Analysis of Modified/Uiunodified Nucleic Acids 
The thermal transition of nucleic acid from native to 
denatured state was characterized as a single variable, fp, 
the fraction of nucleic acid in the denatured state. The 
percent loss in absorbance was used as experimental variable 
to follow the transition. At any given point along the 
transition curve, the observed percent change in absorbance 
was related to the fraction of nucleic acid in the denatured 
state, by the following expression-
(A)obs-(A)N 
fD = 
(A)D-(A)N 
Where, (A)Q]-,g, (A)jg and (A)j-) represent the percent loss 
in absorbance in any observed, native and fully denatured 
states respectively. Since each experimental value of (A)Qj^ g 
will give unique value of (A)ju, the later was used to 
construct transition curves for the thermal denaturation of 
nucleic acids. 
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By assuming that unfolding of the strands of nucleic 
acid is a two state process due to the presence of AT and GC 
regions respectively, the initial and final states of 
thermal denaturation of nucleic acid were related to 
apparent equilibrium constant, defined as: 
(A)oj,s-(A)jj 
^app = 
(A)D- (A)QJ,3 
The free energy change, A G , for the thermal reaction 
(native double stranded conformation to single stranded 
conformation) was calculated by using the following 
relationship 
A G D = -RT in K^pp 
Where, K^pp is the apparent equilibrium constant, R is 
the gas constant (8.314 J/mol/deg) and T is the absolute 
temperature. 
Time Course Kinetic Study of Thermal Energy Melting of 
Unmodified/Modified Nucleic Acids 
The noncovalent/covalent modifications incurred in DNA 
as a consequence of interactions with spermine, protein and 
hormone- protein conjugate were also probed by kinetic of 
thermal melting. 
Time course kinetic analysis of the helix coil 
transition was performed by the method of Warren et al. 
(1974) using the following first order rate equation 
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-In (YfD(oo)-YfD(t)) = a+kt 
Where Y^JU/QQ) and Y^ p^ -^x are the values for the fraction of 
nucleic acid in the denatured state at infinity (i.e. time 
reached at 95°C, where complete separation of the two 
strands occur) and at any time 't' (corresponding to its 
melting temperature). 
The values of -In ^'^fD{Qo)~^fB{t)^ versus time 't' were 
plotted and the apparent first order rate constant was 
determined from the slope. 
Preparation of Heat Denatured DNA 
Purified double stranded DNA was subjected to 20 
minutes heating in a boiling water bath followed by 
immediate chilling on ice-NaCl mixture. Stoppered glass 
tubes were used to prevent evaporation of the solvent. 
Immunization Schedule 
Female rabbits were immunized with the following 
antigens emulsified with equal volume of Freund's 
complete/incomplete adjuvants as per the protocol described 
earlier (Hasan and Ali, 1990). 
(a) 100 ug of estradiol-albumin. 
(b) 50 ug of DNA linked to BSA. 
(C) 50 ug of DNA linked to estradiol-albumin. 
The first injection was given in complete adjuvant and 
for the rest four, Freund's incomplete adjuvant was used. 
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The volume of each injection was kept at 1.0 ml. Blood was 
collected by cardiac puncture after the fourth booster and 
the antibody activity was checked in the immune serum. 
Preimmune serum was obtained from the blood collected before 
immunization. 
Purification and Isolation of IgG 
(a) Preparation of crude immiinoglobulins 
Heat decomplemented serum was precipitated by saturated 
ammonium sulfate solution. To 6.5 ml of the serum was added 
3.5 ml of 100 percent saturated ammonium sulfate solution 
with gentle shaking in cold and the mixture was left for 1 
hr at 4°C for the complete precipitation of immunoglobulins. 
The precipitate was recovered by centrifugation and washed 
thrice with 35 percent ammonium sulfate solution. The washed 
precipitate was dissolved in and dialyzed against 10 mM 
phosphate buffer, pH 8.0. 
(b) DEAE Sephacel chromatography 
Crude immunoglobulins were loaded on a DEAE Sephacel 
column {1.5cm x 22cm) previously equilibrated with O.OIM 
phosphate buffer, pH 8.0. The unbound proteins were washed 
off with the equilibration buffer and the bound material was 
eluted with a linear ionic gradient of 0.01M-0.3M phosphate 
buffer pH 8.0. Fractions of 4.0 ml were collected at a flow 
rate of 20 ml/hr. These fractions were monitored for their 
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absorbance at 251 nm, 278 nm and 280 nm. Peak fractions with 
^278/^251 ^stio of 2.5 or more were pooled as IgG. The 
homogeneity was checked by polyacrylamide gel 
electrophoresis, wherein a single band confirmed that the 
IgG was homogenous (Fig. 3). 
Ismunoa£fiiiity Purification of Antibodies 
(a) CNBr activation of Sepharose 4B 
15 ml of supplied Sepharose 4B was suspended in 
distilled water, and then washed with 300 ml of cold 
distilled water on a sintered glass funnel (porosity G-2). 
Moist gel (about lOg) in 10ml of 2.0 M sodium carbonate was 
kept in ice-NaCl bath placed on a magnetic stirrer. One gram 
cyanogen bromide in 0.8 ml acetonitrile was slowly added to 
the gel with gentle stirring. The reaction was allowed for 
12 min and after that the reaction product was filtered on a 
sintered glass funnel, washed with 400 ml of cold O.Ol M 
sodium bicarbonate and resuspended in 10 ml of the same 
buffer. The unreacted CNBr was treated with ferrous sulphate 
to convert it into harmless ferrocyanide. All steps were 
carried out in a fume-hood chamber (Ali, 1984) . 
(b) Poly-L-lysine coupling to activated Sepharose 4B 
The method described by Wilchek (1973) was followed. 
Immediately after CNBr activation of gel, equal volume of 
poly-L-lysine (100 mg in 10 ml of O.IM sodium bicarbonate) 
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Fig.3. Isolation of IgG from an immune serum 
by DEAE Sephacel chromatography. 
Thirty five percent saturated ammonium 
sulphate precipitated serum proteins 
were loaded onto the column. Peak 
fractions were pooled as IgG. 
Inset: Polyacrylamide gel electrophoretic 
mobility of isolated IgG on 7.5% gel. 
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was added to the activated gel and kept at 4°C for 12 hr 
with slow stirring. The buffer was drained out and the gel 
was washed successively with 100 ml each of cold (i) 
distilled water, (ii) 0.IN HCl, (iii) 0.1 M sodium 
bicarbonate and (iv) distilled water till neutral. Finally 
the gel was suspended in 40 ml of 0.15 M acetate buffer, pH 
4.5. The extent of poly-L-lysine depletion due to its 
covalent coupling with activated Sepharose 4B was calculated 
by TNBS estimation of lysine in the drained effluent as 
described by Habeeb (1966) . 
(c) Affinity isolation of antibodies 
DNA-[polylysyl-Sepharose 4B] was prepared as described 
by Nicotra et al, (1982) with a little modification. 
Previously prepared 20 ml polylysyl-Sepharose 4B was packed 
and equilibrated with 25 ml acetate buffer in a mini column 
(1.5cm X 5 cm). Purified DNA (12.5 ml of 100 /ig/ml) in 
acetate buffer was passed through the gel and unbound DNA 
was washed with PBS, pH 7.4 (Estradiol-albumin-DNA was used 
instead of native DNA for the affinity purification of 
antibodies raised against E2-BSA-DNA). Heat decomplemented 
serum dialyzed against and diluted (1:10) with PBS was 
passed through the column. Unbound proteins were washed with 
PBS and the bound antibodies were eluted with linear ionic 
strength gradient of 0.15-3.0 M sodium chloride in 0.01 M 
phosphate buffer, pH 7.4. Fallthrough fractions were 
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monitored at 251 nm, 260 nm, 278 nm and 280 nm. 
(d) Regeneration of affinity coluam 
The colunin was regenerated several times by washing 
successively with 50 ml each of the following.- (i) distilled 
water, (ii) 0.1 N HCl, (iii) 0.1 M sodium bicarbonate, (iv) 
distilled water till neutral. 
Gel Electrophoresis 
(a) Polyacrylamide slab gel electrophoresis for proteins 
Polyacrylamide slab gel electrophoresis was performed 
under non-denaturing conditions as described by Laemmli 
(1970). The following stock solutions were prepared. 
(i) Stacking gel buffer : 0.5M Tris-HCl, pH 6.8 
(ii) Resolving gel buffer : 3.0M Tris-HCl, pH 8.8 
(iii) Reservoir buffer : 0.025M Tris, 
0.192M glycine 
pH 8.3 
(iv) Acrylamide-bisacrylamide : (30 : 0.8) 
Thirty gram acrylamide and 0.8g bisacrylamide were 
dissolved in distilled water to a total volume of 100 ml. 
The solution was stored at 4°C in an amber colored bottle. 
(b) PAGE procedure 
The glass plates (19cm x 16cm) were soaked in chromic 
acid and thoroughly washed with tap water followed by one 
rinse with distilled water and ethanol. Finally the plates 
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were dried and sealed with 1% agarose with 1.5 mm thick 
spacer separating them. 7.5% separating gel was layered with 
2.5% stacking gel according to the recipe given below (all 
volumes are in ml). 
Solutions Stacking gel Resolving gel 
Acrylamide-bisacrylamide 2.5 7.5 
Stacking gel buffer 5.0 
Resolving gel buffer - 3.75 
Distilled water 10.0 17.25 
1.5% Ammonium persulphate 1.5 1.5 
TEMED 0.02 0.02 
The reagents were mixed and poured between glass 
plates. The gel was allowed to polymerize at room 
temperature and when polymerization was completely achieved, 
the protein sample (25-50jag) containing 10% sucrose and 
0.002% bromophenol blue was applied and electrophoresis was 
carried out at 70 volts for 6-8 hr. It was left for 
overnight staining in 0.1% coomassie Brilliant Blue (R250) 
mixed with 25% iso-propyl alcohol and 10% glacial acetic 
acid. Destaining was carried out by a mixture of 30% 
methanol having 10% glacial acetic acid. 
(c) Slab gel electrophoresis £or native DNA 
The procedure of Sealey and Southern (1985) was 
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followed for electrophoresis of DNA. The following buffers 
were used for the purpose. 
(i) 40% acrylamide in distilled water 
(ii) 2% bisacrylamide in distilled water 
(iii) Resolving gel buffer : 0.9 M Tris-borate, pH 8.3 
containing 0.025M EDTA. 
(iv) Electrode buffer: 0.09 M Tris-borate, pH 8.3 
containing 0.0025 M EDTA. 
Recipe for 7.5% DNA-PA6E (all volumes in ml) 
Solutions Resolving gel Stacking gel 
40% Acrylamide 7.5 1.25 
2% bisacrylamide 7.5 1.25 
Gel buffer 4.0 1.0 
Distilled Water 21.0 6.5 
Ammonium persulphate 50 mg 15 mg 
TEMED 0.025 0.025 
The DNA sample (0.5 -1.0 jug) was mixed with one - tenth 
volume of dye (30% Ficoll, 0.025% xylene cyanol FF in gel 
buffer) and electrophoresed for 6-8 hr at 70 volts. The 
gel was stained with ethidium bromide (1 pg/ml) and DNA 
bands were visualised under UV light. 
(d> Agarose gel electrophoresis of DNA 
Agarose gel was prepared by dissolving agarose NA in 
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electrophoresis buffer (0.04 M Tris-acetate, pH 8.0 
containing 0.002 M EDTA). Molten agarose was poured on the 
gel tray and allowed to solidify for 1 hr at room 
temperature. The DNA samples were electrophoresed for 2-4 hr 
at 30mA in the same buffer. The gel was stained with 
ethidium bromide. 
(e) Gel retardation assay 
The antigen-antibody interaction was analyzed by band 
shift assay. A constant amount of antigen (0.2 jug) was mixed 
with varying amount of antibody (0-20 jug) in a total volume 
of 20-30 ul in O.OIM sodium phosphate buffer, pH 7.4 
containing 0.15M sodium chloride. The complex was incubated 
for 2 hr at room temperature and overnight at 4°C. At the 
end of incubation, 2 lal dye solution was added to each tube 
and the complex was electrophoresed on agarose gel for 2 hr 
at 30 mA using Tris-acetate EDTA (pH 8.0) buffer. On 
completion of electrophoresis, gels were stained with 
ethidium bromide and photographed under UV illumination. 
Appropriate controls were also run simultaneously. 
Detection and Quantitation of Antibodies 
(a) Immunodiffusion (ID) 
ID was carried out by ouchterlony double diffusion 
system using glass petridishes. Six ml of 0.4% molten 
agarose in PBS, pH 7.4 containing 0.1% sodium azide was 
67 
poured onto glass petridishes and allowed to solidify at 
room temperature and then kept at 4°C for four hours. Wells, 
each 5mm in diameter and separated by a 8 mm distance were 
cut into the hardened gel by a cork borer. Antigen and 
antibodies were placed in the wells and the reaction was run 
for 48-72 hr at room temperature.The petriplates were washed 
with 5.0% Na-citrate for two hours to remove nonspecific 
precipitin lines, if any. 
(b) Counterinnniino-electrophoresis (CIE) 
The method of Kurata and Tan (1976) was followed for 
performing CIE. Molten agarose (0.6%) in 0.025M barbital 
buffer, pH 8.4 containing 0.1% sodium azide was poured onto 
2.5 mm thick glass slides (2.5cm x 7.5cm) and allowed to 
harden at room temperature and then at 4°C. Wells, each 3mm 
in diameter were filled with antigen (in the cathodal well) 
and antibodies (in the anodal well). Electrophoresis was 
performed for 30 min in 0.05M barbital buffer, pH 8.4 under 
3-4 mA current per slide. Non specific precipitin lines were 
removed by 5% sodium citrate solution washing. 
(c) Enzyme-linked iomxinosorbent assay (ELISA) 
(i) Buffers and reagents 
Tris buffer saline (TBS) .- O.OIM Tris 
0.15M NaCl 
pH 7.4 
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Tris buffer saline Tween-20 
(TBS-T) 
Bicarbonate buffer 
2-amino-2 methyl-1-propanol 
(AMP) buffer 
Substrates 
0.02 M Tris 
0.144 M NaCl 
0.00268 M KCl 
pH 7.4 containing 
500 Ml Tween-20 
0.015 M Sodium carbonate, 
0.035 M Sodium bicarbonate, 
pH 9.6 
0.15 M AMP Containing 
0.003 M MgCl2, pH 10.3 
(a) 500 ug p-nitrophenyl 
phosphate per ml of 
bicarbonate buffer 
containing 0.002 M MgCl2• 
(b) 4-methyl umbelliferyl 
phosphate (4 MU-P) in 
0.15 M AMP buffer. 
(ii) ELISA procedure 
The procedure of Aotsuka et al. (1979) with slight 
modification (Alam and Ali 1992) was used for detection and 
quantitation of antibodies formed against E2-BSA, E2-BSA-DNA 
and DNA-BSA conjugate. 
Polystyrene microtiter plates were coated with 100 ul 
of either of the three antigens, (E2-BSA, E2-BSA-DNA or DNA-
BSA) in bicarbonate buffer at a concentration of 5 pg/ml for 
E2-BSA and 2.5 jug/ml for the other two. The plates were 
incubated at 37°C for 2 hr followed by overnight incubation 
at 4*0. The plates were washed three times with TBS-T and 
the unoccupied sites were blocked by 150 jul/well of 1.5% BSA 
in TBS for six hours at room temperature (10% skimmed milk 
was used to block unoccupied sites when antibodies against 
DNA-BSA were used). The plates were washed twice with TBS-T 
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and the antibody (100 yl/well) to be tested, diluted in TBS 
was added to each well. After two hours incubation at 37°C 
and overnight at 4«*C, the plates were washed four times with 
TBS-T. Bound antibodies were assayed by an appropriate 
anti-immunoglobulin alkaline phosphatase conjugate using p-
nitrophenyl phosphate as substrate. The plates were 
incubated at 37«>C for 30 min and the reaction was stopped 
by adding 100 ul of 3 M NaOH solution to each well. Each 
sample was coated in duplicate and the absorbance of each 
well was monitored at 410 nm. Results were expressed as a 
mean of A^eg^-A^Qntrol• 
ELISA for Anti-DNA Antibodies 
Polystyrene microtiter plates were incubated with 100 
ul of poly D-lysine solution (50 iug/ml in distilled water). 
The plates were washed three times with TBS and coated with 
100 «1 of antigen (ds DNA) at a concentration of 2.5 ug/ml 
in TBS for two hours at 37°C followed by overnight 
incubation at 4'*C. The plates were washed three times with 
TBS-T and saturated with 100 M1 of poly L-glutamate (50 
lig/ml in TBS) for two hours at room temperature. Rest of the 
steps were same as in the previous case. 
ELISA for the Binding of SLE Autoantibodies to S-Estradiol 
ELISA was performed on 96 well flat bottom polystyrene 
plates with slight modification in the procedure described 
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earlier. 
The plate was precoated with 100 yl/well poly-L-lysine 
(100 Mg/ml in CO3/HCO3 buffer, pH 9.6) for 2 hr at 37°C. 
After three washings with TBS (10 tnM Tris, 150 niM NaCl pH 
7.4) test wells were coated with 100 ml S-estradiol (2.5 
/ag/ml in double distilled ethanol). The plate was kept for 2 
hr at 37°C and overnight at 4°C and then washed thrice with 
TBS-T (20 mM Tris, 150 mM NaCl, pH 7.4 containing 0.05% 
Tween-20). Hundred microlitre of poly-L-glutamate (50 jug/ml 
in TBS, pH 7.4) was coated to each of the antigen coated 
wells for 2 hr at 37°C. After three wash with TBS-T, the 
plate was filled with 150 ;ul of 1.5% TBS-BSA and incubated 
for 5 hr at 37°C. Antibody (100 ul/well) to be tested was 
added to each well in different dilutions. The plate was 
left for 2 hr at 37°C and overnight at 4°C. Bound antibodies 
were assayed with anti-human IgG alkaline phosphatase 
conjugate (1:1500 dilution in TBS) using p-nitrophenyl 
phosphate and 4MU-P ( in 0.15 M AMP buffer) as substrate. 
The contents of each well were read at 410 nm on an 
automatic microplate reader for PNPP, and fluorometric 
measurements (using 4 MU-P as substrate) were made on RF-540 
Shimadzu spectrofluorophotometer equipped with a DR-3 data 
recorder. 
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Inhibition ELISA 
The antigen binding specificity of antibody was defined 
by competition-inhibition experiments (Hasan et al, 1991). 
Varying amounts of inhibitors were mixed with a constant 
amount of antiserum or IgG. The mixture was incubated for 2 
hr at 37°C and 16-20 hr at 4°C. Instead of serum, the 
resulting immune complex was used in ELISA. The results were 
expressed as percent inhibition. 
^ inhibited 
% Inhibition = 1 - x 100 
uninhibited 
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Purified native calf thymus DNA was modified by (a) 
bromination under high and low salt conditions, (b) 
interaction with polyamines, (c) covalently linking DNA 
(average size 200 bp) to BSA and E2-BSA respectively. The 
modified polymers were characterized by physico-chemical 
methods and their antigenecity was evaluated by immunization 
in experimental animals. 
nv Absorption Properties of Brominated DNA 
Native calf thymus DNA brominated in low (0.15 M NaCl) 
and high salt (4.0 M NaCl), when subjected to UV-spectro-
scopy under physiological conditions showed the 
characteristic hypochromicity at 260 nm with concomitant 
hyperchromicity at 295 nm compared to the spectrum of native 
DNA. The Amin (under high salt) was shifted from 230-242 
nm, while no appreciable shift was observed in the case of 
low salt sample (Fig. 4a). The UV difference spectra of the 
above samples exhibited positive band peaking at around 300 
nm. The effect was less pronounced in the DNA sample 
brominated in low salt. (Fig. 4b). The UV-absorption 
characteristics of native and brominated DNA sample under 
physiologically compatible conditions are listed in Table 3. 
The data show around 60% decrease in absorbance as a result 
of bromination in high salt, while only 27.5% decrease was 
observed for the low salt brominated polymer. The 
conformational changes in DNA were also evaluated by 
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Pig.4. (a) Ultraviolet absorption spectra of native 
calf thymus DNA( ), brominated in 0.15M 
( ) and in 4 . OM ( ) NaCl. 
(b) UV difference spectra of native DNA 
brominated in low ( ) and high ( ) 
salt. Unbrominated DNA served as control. 
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quantitative measurements of absorbance at 260 nm and 295 
nm. The absorbance ratio (A295/A2go) ^^^ 0.130 for native 
DNA, 0.188 for native DNA brominated under physiological 
conditions of saline and 0.35 for the polymer brominated in 
high salt (Table 3) . It could be noted here that the 
absorbance ratio (-^ 295^ 2^ 0^  is ^-^ ^o^ Z-DNA (Thomas and 
Strobel, 1988). 
Circular Dichroism o£ Native and Brominated DNA 
Double stranded poly(dG-dC) undergoes B->Z transition 
in high salt. The circular dichroism (CD) of this polymer in 
high salt shows near inversion of the spectrum with a 
positive band at 264 nm and a negative band at 2 94 nm (Fig. 
5). This CD inversion has been established as a 
characteristic feature of Z-conformation. In this study, 
native DNA showed a negative peak at around 244 nm and a 
positive peak (maxima) corresponding to 274 nm (Fig. 6a) . 
After bromination in high salt, near inversion in the CD 
spectrum was noticed with a positive band at 255 nm and a 
negative band at 294 nm (Fig. 6b) . For low salt brominated 
form, no spectral inversion was noticed. 
tTV Spectroscopic Behavior of DNA-Polyamine Cos^lex 
The UV spectroscopic behavior of native calf thymus DNA 
(50 Mg/ml) complexed with 100 Aig/ml each of spermine, 
spermidine and putrescine has been depicted in Table 4. 
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TAfiLE 3 
UV Absorption Character!stcs of Native and Brominated DNA 
Absorption DNA Polymers 
Characteristics 
native DNA Br4 BrN 
Amax (^"^^  258 258 258 
Aniin (^"^) 230 242 232 
Absorbance at 260 nm 2.08 0.84 1.50 
Percent decrease in 0 59.6 27.5 
absorbance at 260nm 
Absorbance ratio 0.130 0.35 0.188 
(A295/A260) 
Br4 and BrN represent native calf thymus DNA brominated in 
4 M and 0.15 M NaCl. 
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Fig.6. (a) Circular dichroism spectrum of 
calf thymus DNA in TBS, pH 7.4. 
native 
(b) Circular dichroism spectra of native DNA 
brominated in 0.15M ( ) and in 4.0M ( ) 
NaCl. The spectra were recorded in TBS, pH 
7.4. 
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TAfLE 4 
UV Absorption Characteristics of Native Calf Thymus DNA 
Costplexed with Polyamines 
native DNA Absorbance at Absorbance ratio Percent relative 
complexed 260 nm 295 nm ^^295/'^26o' increase in the 
with absorbance ratio 
1.473 0.153 0.104 
Spermine 1.484 0.196 0.132 26.92 
Spermidine 1.455 0.185 0.127 22.12 
Putrescine 1.425 0.176 0.124 19.23 
The data represent the afithmatic mean of triplicate 
samples. The absorbance of polyamine (100 ug/ml) alone was 
substracted from the sample containing native DNA and 
polyamines. 
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Native calf thymus DNA exhibited enhanced absorbance in the 
presence of polyamines. The data conclusively shows 
increased absorbance ratio in the presence of the above 
three polyamines. The percent relative increase in 
absorbance ratio was in the range of 19 to 27. On the other 
hand, when poly(dG-dC).poly{dG-dC) was exposed to varying 
concentrations of spermine, under identical conditions, it 
showed more than 60 percent increase in the absorbance ratio 
even when the polyamine concentration was 40 yg/ml (Table 
5). Increased UV absorbance at around 295 nm has been found 
related to the structural perturbations in the classical B-
DNA helix. It has earlier been shown that the double 
stranded poly(dG-dC) attains Z-conformation in 4 M NaCl and 
the observed absorbance ratio (A295/A2go^ °^ 0.30. 
Binding of Anti-Z-DNA Antibodies to DNA-Polyamine CoiiQ>lex 
The B->Z transition of purified native calf thymus DNA 
in the presence of polyamines was further probed by ELISA. 
The binding of anti Z-DNA antibodies to DNA in the presence 
of varying concentrations of spermine, spermidine and 
putrescine shows the B->Z transition of DNA. (Fig. 7) . The 
enzyme immunoassay was conducted as described by Thomas and 
Messner (1988). The experimentally induced antibodies 
against Z-DNA did not recognize native DNA in the absence of 
polyamines. But, in their presence, the antibody binding was 
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TABLE 5 
UV Absorption Characteristics of Poly (dG-dC).poly (dG-dC) 
Complexed with Varying Concentrations of Spermine 
Poly(dG-dC) Absorbance at Absorbance ratio Percent relative 
with 260 nm 295 nm •^^ 29 5''''^26 0 ^  increase m the 
Spermine (»jg/ml) absorbance ratio 
0 0 . 6 2 0 0 . 1 2 0 0 . 1 9 4 
10 0 .634 0 .156 0.246 26.8 
20 0 .644 0 . 176 0.273 40.7 
40 0 .627 0 . 198 0. 316 62 . 9 
50 0.615 0 .193 0.314 61.8 
100 0.600 0.188 0.313 61.3 
The data represent arithmatic mean of triplicate samples of 
control and experimental. The absorbance of spermine in each 
set was substracted from the experimental value. 
81 
POLYAMINE / DNA RATIO 
Fig.7. Enzyme-immunoassay detection 
of anti-Z-DNA antibody binding 
to native DNA (—#-) , and 
native DNA complexed with 
varying amounts of spermine 
(-<>- ) , spennidine (—^ ) and 
putrescine (^ i!^  ) . The colour 
was developed for 45 min and 
absorbance read at 410 nm. 
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found to increase with increasing concentration of 
polyamines. In this case, both spermine and spermidine were 
almost equally effective in the conversion of B-DNA to Z-
conformation while putrescine appears less effective. Double 
stranded poly(dG-dC) complexed with varying concentrations 
of polyamines served as the comparative control for the 
binding of anti-Z-DNA antibody to polyamine induced Z-
conforroation of DNA. Here, comparatively lesser amount of 
polyamines were required to bring about the said 
conformational change. Anti-Z-DNA antibodies showed no 
binding with double stranded poly (dG-dC) (Fig. 8). 
Characterization of DNA-BSA and E2-BSA-DNA Conjugates 
Purified calf thymus DNA (average size 200 bp) was 
covalently linked to BSA and E2-BSA using glutaraldehyde as 
the crosslinking reagent. Crosslinked product was purified 
free of unlinked species on a Sephadex G-200 column. The 
column fractions in both the cases were analysed for the 
presence of DNA and BSA by the method of Burton (1956) and 
Lowry et al. (1951) respectively (Figs. 9 & 10). These 
fractions were also monitored for absorbance at 260 nm and 
280 nm. Fractions containing both DNA and protein were 
pooled and taken as DNA-BSA and E2-BSA-DNA conjugates. These 
conjugates were analysed by ultraviolet spectroscopy (Table 
6). A red shift of 8 nm (from 230 to 238 nm) and 11 nm (from 
230 to 241 nm) was observed in the minima of DNA after its 
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POLYAMINE / DNA RATIO 
Fig.8. Enzyme-immunoassay titration 
of anti-Z-DNA antibody binding 
to poly(dG-dC).poly(dG-dC) 
( 0 ), and the polymer mixed 
with varying amounts of 
spermine (-0~) / spermidine 
( A ) and putrescine (—A-) . 
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Fig.9. Elution profile of DNA-BSA conjugate on 
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were monitored for absorbance at 2 60 nm 
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analyzed for protein (—Q—) and DNA (—*—) by 
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TABLE 6 
nv- Absorption Characteristics of Native and Modified DNA 
Fragment (average size 200 bp) 
Species A max (in nm) '^ min (in nm) 2^6o/'^ 280 
DNA 
BSA 
DNA-BSA 
258 
278 
258 
E2-BSA 278 
E2-BSA-DNA 258 
230 
250 
238 
255 
241 
2.2 
0.6 
1.6 
0.88 
1.45 
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linkage to BSA and E2-BSA respectively (Figs. 11 & 12). The 
E2-BSA and E2-BSA-DNA spectra exhibited marked differences 
in their UV absorption pattern (Fig. 12). A blue shift of 14 
nm in the minima and a shift of 20 nm in the maxima of E2-
BSA was observed after its covalent linkage to DNA. A 
substantial decrease in absorbance of linked E2-BSA around 
300 nm was also observed. Results of these studies indicate 
that DNA is linked to BSA and E2-BSA. 
Thermal Denaturation Studies 
The thermal denaturation of native and modified DNA was 
investigated between 30°C and 95''C. The process was 
characterised by determining the percent fraction of nucleic 
acid in denatured state at various temperatures as well as 
by the evaluation of Tm. The increase in UV absorbance at 
260 nm was recorded as a function of rise in temperature at 
a rate of 1.0°C/min and taken as a measure of the extent of 
denaturation. 
When DNA-spermine complex was heated from 30°C to 95°C 
on an electronically controlled heating device, the helix 
opening started after 86°C and the melting temperature (Tm) 
was 89''C, while in the case of corresponding control (i.e. 
native DNA), significant heat induced strand separation was 
noticed after 85°C and Tm was 87°C (Fig. 13) . 
While in another set of experiments, when native DNA 
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Fig.13. Melting profile of native 
DNA (-0-) and DNA-spermine 
complex (-0-) • Melting 
temperatures were recorded 
at an increment of l°C/min. 
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(-200 bp) and its modified forms, viz., E2-BSA-DNA and DNA-
BSA conjugates were subjected to heat induced helix opening, 
no denaturation or strand separation was visualized till 
75°C in case of DNA and E2-BSA-DNA conjugate. While in case 
of DNA-BSA conjugate, the duplex melting started at 50°C. 
The Tm values for native DNA (-200 bp) , E2-BSA-DNA and DNA-
BSA were 83.5°C, 85°C and 82''C respectively (Fig. 14). 
Thermodynamical Analysis of Unmodified and Modified Nucleic 
Acids 
The modifications incurred in native DNA and native DNA 
fragments of around 200 base pairs as a result of spermine, 
BSA and E2-BSA interactions was also investigated by means 
of thermodynamic analysis (Table 7) . The free energy of 
thermal denaturation ( A G^) for native DNA was found to 
decrease linearly from 30°C-85°C. The ^ Gj^  for native DNA 
was computed to be -14.85 K.cal.deg"-^ at 40<'C and -6.6507 
K.cal.deg"-^ at 85°C. The high negative values for A G^ from 
30''C-85°C indicate the tremendous stability exhibited by the 
double helical nucleic acid. Moreover, the large negative 
values till 85 °C indicate that the thermal energy being 
implied on the native DNA to break the bonds between guanine 
and cytosine (G=C) and adenine and thymine (A=T) was 
encountering a strong opposition from these stable bonds and 
thus the DNA double helix was not appreciably disrupted till 
85°C. On the other hand, further elevation in temperature 
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TABLE 7 
Thermodynamic Characteristics of Unmodified/Modified Nucleic 
Acids 
Temperature AGT-, in K.cal .deg. "•'• 
(Abs .) 
native native DNA DNA- DNA-BSA E2-BSA-DNA 
DNA (-200 bp) Spermine 
308.15 - -12.531 -8.146 - -9.234 
313.15 -14.850 -10.951 -6.575 -12.551 -7.104 
318.15 -11.450 -11.126 -5.713 -12.751 -6.395 
323.15 -10.158 -13.141 -4.623 12.907 -5.886 
328.15 -9.126 - -3.970 10.064 -5.726 
333.15 -8.262 -13.548 -3.514 7.776 -5.475 
338.15 -8.073 - -3.808 7.496 -5.557 
343.15 -8.192 -10.863 -3.406 7.245 -5.749 
348.15 -8.164 14.112 -2.813 5.500 -6.490 
350.15 - 14.193 - - -6.221 
353.15 -8.058 4.889 -2.616 2.143 5.881 
355.15 - - _ _ 3.216 
358.15 -6.650 -1.187 -0.467 2.173 -0.542 
359.65 11.160 - -0.407 
360.15 - -2.711 - -3.942 
361.15 4.623 - 2.751 - 2.534 
363.15 0.281 -6.684 -1.897 -7.051 -6.254 
364.15 -0.687 - -3.153 
365.15 -3.961 • - - -7.045 
366.15 - -10.550 - - -9.031 
367.15 -16.586 - _ . . 
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(from 86.5°C to 90°C) showed positive -^  G^ values. The A Gj^, 
values were computed to be 11.16 K.cal .deg"-"- at 86.5°C and 
0.281 K.cal.deg"-'- at SO^C. The positive values of ^ G^ here 
indicate the transition from native to the denatured state. 
Further elevation in temperature showed a shift in A Gj-, 
values from the positive scale towards the negative side, 
thereby indicating the complete attainment of separation of 
the two strands as a result of thermal denaturation. 
In the case of DNA-spermine complex, the A GQ was 
computed to be -8.146 K.cal.deg"-^ at 35°C which decreased 
linearly to -0.407 at 86.5°C. The large negative ^ G-Q values 
from the initial stages of melting till 86.5°C indicates 
that the interaction of spermine with DNA resulted in the 
formation of a more stable nucleic acid conformer, judged on 
comparative basis of ^ GT-, values, which was found to 
decrease linearly till 86.5°C in DNA-spermine complex. Thus, 
the ^ Gj2 values depicted in Table 7 indicate DNA-spermine 
complex to be more thermodynamically stable than native DNA. 
In contrast to native DNA, the A Gp values for 200 bp 
DNA fragment decreased linearly from 35°C to 70°C and not 
till 85^0 as was the case with native DNA. Comparison of the 
AGJ-) values indicate that the 200 bp DNA fragment was 
thermodynamically less stable than native DNA. 
The thermodynamical analysis of 200 bp DNA linked to 
BSA via glutaraldehyde (DNA-BSA) exhibited negative A G^ 
95 
values only till 45°C. The A Gj^  value at 45°C was computed 
to be -12.751 K.cal .deg"-'-. Further elevation in temperature 
exhibited a sharp transition of the A G^ values from the 
negative side towards the positive scale. The abrupt shift 
in the negative A G^ values above 45°C to positive A G^ 
value (+12.907 K.cal. deg"-"- at 50°C) indicates that some 
portions of the DNA-BSA complex were already in the 
unstacked form. The results depicted in Table 7, reveal that 
DNA-BSA complex was thermodynamically less stable than 200 
bp DNA. 
In case of E2-BSA-DNA, the ^ G^ , values decreased 
linearly from 35°C to 77°C. The ^ G^ value was computed out 
to -9.234 K.cal.deg"^ at 35°C and -6.221 K.cal.deg'^ at 
77°C. However, further elevation in temperature resulted in 
the shift of ^ G^ values towards positive side. Furthermore, 
comparative analysis with 200 bp DNA shows that the E2-BSA-
DNA macromolecule exhibited negative A Grj values right from 
the initial stages of melting till 77°C whereas, 200 bp DNA 
exhibited negative A Gj-, values till 70°C. The negative ^ G^ 
values before melting signify the degree of stability of the 
macromolecule. Thus, the results indicate that E2-BSA-DNA 
was thermodynamically more stable than DNA of 200 bp. 
Detection of Modification by Time Course Kinetic Analysis 
The process of modification or/perturbations in the 
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native DNA as well as 200 bp native DNA fragment as a result 
of spermine, BSA and E2-BSA interactions was characterized 
by the measurements of fractions of nucleic acid in the 
denatured state, fj-,, with time, 't'. 
As evident from Fig. 15, the fj^  values for native DNA 
were of every low magnitude upto 55 min of heating (85°C) . 
However, an abrupt increase in fp value was observed from 56 
to 64 min corresponding to thermal denaturation temperatures 
of Se^C to 940c. The t-L/2 (half-life) of thermal 
denaturation for native DNA was computed to be 59 min. On 
the contrary, DNA-spermine complex formed as a result of 
ionic interaction exhibited a very low magnitude of fj-j 
values upto 58 min of heating (88°C). Thus, in comparison to 
native DNA, the DNA-spermine complex showed very low 
magnitude of t-^ values for a greater period of heating time 
(i.e. by 3 min). The half life (ti/2) for thermal 
denaturation of DNA-spermine complex was computed to be 60 
min. The results indicate that DNA-spermine complex was 
thermodynamically more stable than native DNA. 
In case of 200 bp DNA, no progressive increase in f^ 
values was observed till 45 min (75°C) (Fig 15) . A rapid 
increase in the fj-, value was observed from 45-65 min of 
heating at (75°C-93°C) . The t-j^/2 value in this case was 
found to be 55 min (85°C). 
In contrast to 200 bp DNA, the DNA (200 bp) linked 
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Fig.15. Time course kinetic plot for 
thermal transition of 
modified and unmodified 
nucleic acids. Native DMA 
(—A-), DNA-spermine complex 
(-*-), -200 bp DNA (-#-), 
DNA-BSA {-Q-) and E2-BSA-DNA 
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covalently to BSA via glutaraldehyde exhibited a low f^  
value only till 20 min of heating (50°C) (Fig. 15). However, 
further elevation in temperature till 60 min of heating 
produced an abrupt increase in its fp values. The ^1/2 here 
was computed to be 51.5 min. The results show that DNA-BSA 
started melting 25 minutes earlier than native 200 bp DNA, 
thereby indicating that covalent conjugation of BSA via 
glutaraldehyde to 200 bp DNA resulted in the unstacking of 
the DNA macromolecule, thereby rendering it 
thermodynamically less stable. 
However, when E2-BSA-DNA was subjected to thermal-
kinetic studies, it showed an f^  value of low magnitude till 
50 min of heating (80°C) (Fig. 15) . Comparative analysis 
with 200 bp DNA shows that E2-BSA-DNA required an additional 
5 min of heating as revealed by the f^ , values, thereby 
indicating that coupling of E2-BSA to 200 bp DNA resulted in 
the formation of a thermodynamically more stable conformer. 
The half life (t-j^ /2) i^ this case was computed out to be 56 
min. 
Also, the order of the denaturation process was 
determined by plotting -^ (^Yfj-,^ ^ j-Y^ jj^ ^^  ) versus time. A 
straight line for the modified and unmodified DNA indicates 
the first order rate denaturation. The apparent first order 
rate constant was determined from the slope of the plot. 
Native DNA (200 bp) , DNA-spermine complex, E2-BSA-DNA and 
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DNA-BSA exhibited apparent first order rate constants of the 
order of 4.5045 x lO"'* sec""'-, 5.316 x 10"^ sec""'-, 2.1645 x 
10"^ sec"-^  and 2.4038 x lO"** sec"-^  respectively (Figs. 16 to 
19). These kinetic parameters are depicted in Table 8. 
Production and Characterization of Antibodies Against E2-
BSA, E2-BSA-DNA and DNA-BSA Conjugates 
Antibodies against E2-BSA, E2-BSA-DNA and DNA-BSA 
conjugates were induced in female rabbits. The serum was 
separated from the immunized blood samples and tested for 
the presence of antibodies, against their respective 
iramunogens, by immunodiffusion, counterimmunoelectrophoresis 
and ELISA techniques. 
(a) Antibodies against E2-BSA conjugate 
Anti-E2-BSA antibodies were found to be non-
precipitating as indicated by immunodiffusion. The antibody 
titer was found to be >1:12800 (Fig. 20) in direct binding 
ELISA. Preimmune serum showed low binding. The specificity 
of these antibodies was checked by competition ELISA using 
immunizing antigen as the inhibitor. The maximum inhibition 
in the antibody binding was 93 percent at an inhibitor 
concentration of 15 ug/ml (Fig. 21). Fifty percent 
inhibition was obtained at an inhibitor concentration of 1.0 
jug ml"-^. Anti-E2-BSA antibody binding was subjected to 
competition from various inhibitors. Besides the immunizing 
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Fig.16. First order thermal 
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TABLE 8 
Apparent First Order Rate Constants for Thermal Denaturation 
Nucleic Acid App.First Order Rate Constant (K) 
1. native DNA-Spermine 
2. native DNA (-200 bp) 
3. E2-BSA-DNA 
4. DNA-BSA 
5.316 X 10"^ sec"^ 
4.5045 X 10 "^  sec ^ 
2.1645 X 10"* sec ^ 
2.4038 X 10 '* sec ^ 
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antigen, 86%, 53% and 23% inhibitions were obtained with E2-
BSA-DNA, estradiol and histone (H2A) respectively at an 
inhibitor concentration of 15 yxg ml" . Inhibition with 
native DNA, ssDNA, RNA, Br-DNA, poly(rG). poly(dC), DNA-BSA 
and BSA was negligible (Table 9; Figs. 22 & 23). 
(b) Antibodies against E2-BSA-DNA conjugate 
Antibodies raised against E2-BSA-DNA conjugate were 
also non-precipitating. The antibody titer as detennined by 
direct binding ELISA was >1:12800 (Fig. 24). The binding of 
preimmune serum was of low magnitude. The specificity of 
induced antibodies was explored by competition assay. Table 
10 shows the results obtained with various inhibitors. 
Studies were also performed on ion-exchange and affinity 
purified IgG. A maximum of 91% inhibition in the antibody 
(IgG) activity was caused when immunogen was used as 
inhibitor (Fig. 25). Fifty percent inhibition was observed 
at an inhibitor concentration of 0.09 jug ml"-^. Besides the 
immunogen, significant inhibition was caused by estradiol-
albumin and S-estradiol (Fig. 25). Almost negligible 
inhibition was obtained with native DNA, DNA-BSA, 
poly(rG).poly(dC), Br-DNA and histone. Heat denatured DNA 
and RNA were inhibitory but at a higher inhibitor 
concentration (Figs. 25 & 26; Table 11). Results obtained 
with affinity purified anti-E2-BSA-DNA IgG are shown in 
Table 12. 
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TABLE 9 
Con^etitive Inhibition of Anti-E2-BSA Antibodies 
Competitor Concentration for Percentage Percentage 
50% inhibition inhibition relative 
(pg/ml) affinity 
E2-BSA 
Ej-BSA-DNA 
DNA-BSA 
S-estradiol 
BSA 
Poly(rG).poly(dC) 
Histone (H2A 
native DNA 
ss DNA 
RNA 
Br-DNA 
1.0 
1.2 
9.0 
93.0 
86.0 
53.0 
23.0 
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TABLE 10 
Competitive Inhibition Data of Anti-E2-BSA-DNA Antibodies 
Competitor Concentration for 
50% inhibition 
(ug/ml) 
Percentage 
inhibition 
E2-BSA-DNA 
E2-BSA 
S-estradiol 
native DNA 
DNA-BSA 
BSA 
Heat denatured DNA 
RNA 
Brominated DNA 
Poly{rG).poly(dC) 
Histone (H2A) 
1.2 
1.0 
81 
80 
48 
38 
31 
18.0 
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[INHIBITOR] iLg/ml 
F i g . 2 5 . I n h i b i t i o n of anti-E2-BSA-DNA IgG by E^-BSA 
( - 0 - ) , E2-BSA-DNA ( - # - ) , DNA-BSA ( - T ^ f , S-
e s t r a d i o l {—Q-) and Br-DNA ( - A - ) . 
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TABLE 11 
Cos^etitive Inhibition Data of Anti-E2-BSA-DNA IgG 
Competitor Concentration Percentage Percent 
for 50% inhibition relative 
inhibition affinity 
(ug/ml) 
E2-BSA-DNA 
E2-BSA 
S-estradiol 
native DNA 
DNA-BSA 
BSA 
Heat denatured DNA 
RNA 
Brominated DNA 
poly(rG). poly(dC) 
Histone(H2A) 
0.09 
0.1 
0.3 
40.0 
91 
89 
83 
54' 
49 
100 
90 
30 
0.2 
19 
* inhibition at 75 ug/ml. 
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TABLE 12 
Inhibition of Affinity Purified Anti-E2-BSA-DNA IgG 
Competitor 
E2-BSA-DNA 
E2-BSA 
S-estradiol 
native DNA 
DNA-BSA 
Concentration 
for 50% 
inhibition 
(ug/ml) 
0.08 
0.1 
0.4 
-
_ 
Percentage 
inhibition 
95 
87 
80 
-
_ 
Percentage 
relative 
affinity 
100 
80 
20 
-
-
BSA 
Heat denatured DNA 
RNA 
Brominated DNA 
P o l y ( r G ) . poly(dC) 
36 
60 
57 
51" 
0.22 
0.13 
* i n h i b i t i o n a t 75 jug/ml 
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(c) Antibodies against DNA-BSA conjugate 
Anti-DNA-BSA antibodies were found to be 
precipitating as a sharp precipitin line was evident in 
immunodiffusion (Fig. 27). Direct binding ELISA on 
polystyrene plates coated with the immunizing antigen 
indicated high binding activity (>1:1600) (Fig. 28) . To 
check the antibody specificity, competition ELISA was 
performed by employing DNA-BSA as inhibitor. A maximum of 
83% inhibition in the antibody activity was recorded at an 
inhibitor concentration of 15 pg ml""^ (Fig. 29) . Fifty 
percent inhibition was seen at an effective inhibitor 
concentration of 1.4 \xg ml"-'-. Varying degrees of inhibition 
in the antibody activity was obtained with various 
inhibitors. Native DNA, ss DNA, RNA, E2-BSA, E2-BSA-DNA, 
poly(rG).poly(dC) and Br-DNA were not inhibitory (Figs. 29 & 
30) . 
Recognition of Brominated DNA by SLE Autoantibodies. 
The interaction of anti-DNA autoantibodies with the Z-
conformation of poly (dG-dC).poly(dG-dC) has been reported 
(Lafer et al., 1983b; Bergen et al. , 1987; Krishna et al. , 
1993). Very few studies (Ali et al. 1991; Ali and Ali., 
1993) have reported B->Z conversion in calf thymus DNA and 
its subsequent recognition by anti-DNA autoantibodies. The 
binding by SLE autoantibodies to native DNA brominated in 
high salt was checked in direct binding ELISA. The results 
Fig.27. Immuno-crossreactivity of 
anti-DNA-BSA antibodies. 
1. DNA-BSA conjugate. 
2. Anti-E2-BSA-DNA antibody. 
3. Anti-E2-BSA antibody. 
4. Anti-DNA-BSA antibody. 
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show almost similar binding of anti-DNA antibodies to native 
and Z-form of calf thymus DNA (Figs. 31 & 32). In 
competition-inhibition experiments, when compared with 
native DNA, the Br-DNA appeared equally effective inhibitor 
of anti-DNA antibody binding to native DNA (Figs. 33 & 34). 
SLE Autoantibody Binding to Spermine-DNA Contplex 
Of all the polyamines, spermine causes maximum 
perturbation in nucleic acid conformation. Though the B->Z 
transition of synthetic polynucleotides in the presence of 
spermine has been documented (Thomas and Messner, 1988; 
Thomas et al., 1990), no substantial effort has been made to 
probe the B->Z transition of calf thymus DNA. The polyamine 
induced Z-form is also significant because it is achieved in 
physiological conditions of saline. The spermine induced Z-
DNA also showed very high degree of recognition for SLE 
autoantibodies both in direct binding and competition ELISA 
(Figs. 35 & 36). 
Recognition of Estradiol-BSA-DNA Conjugate by SLE 
Autoantibodies 
Three SLE sera having high titer anti-DNA antibodies 
(>1:6400) with preference for native DNA were obtained from 
patients falling under the criteria laid down by American 
Rheumatism Association for this disease. Estradiol-albumin-
DNA conjugate, DNA-BSA conjugate and native DNA were 
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Fig.31. Direct binding assay of anti-DNA 
autoantibodies. The plate was coated with 
native DNA. Normal human serum ( A-) , SLE 
sera e#-,'^;0) . 
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Fig.33. Inhibition of SLE anti-DNA antibodies by 
native DNA. The plate was coated with native 
DNA. 
i/^b 
0.1 0.2 
CINHIBIT0R3 >i9/ml 
10 20 
Fig.34. Inhibition ELISA of SLE anti-DNA antibodies. 
The competitor was brominated DNA and the 
coating antigen was native DNA. 
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Fig.35. Direct binding assay of anti-DNA 
antibodies on the plate coated with DNA-
spermine complex. Normal human serum 
(-A-) . SLE sera (-#-;-©-;<», 
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Fig.36. Inhibition of SLE anti-DNA autoantibodies by 
DNA-spermine complex. The plate was coated 
with native DNA. 
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employed as competitors of antibody binding to the native 
DNA coated on polystyrene plate. A high degree of inhibition 
of SLE anti-DNA antibodies was observed with E2-BSA-DNA 
conjugate (Fig. 37) at an inhibitor concentration of 15 ^g 
ml"-"-. This signifies the recognition of SLE anti-DNA auto-
antibodies by E2-BSA-DNA conjugate. The binding of SLE 
autoantibodies to native DNA and E2-BSA-DNA was also 
assessed by gel retardation assay. When mixtures of SLE 
anti-DNA antibodies (IgG) and native DNA were subjected to 
agarose gel electrophoresis the complexes showed different 
degree of retarded mobility (Fig. 38a) . With increasing IgG 
concentration the amount of immune complexes formed also 
increased as revealed by fluorescence intensity, whereas the 
amount of unbound DNA showed a proportional decrease. When 
complexes of SLE IgG and E2-BSA-DNA were electrophoresed on 
agarose gel under identical conditions, the retarded 
mobility as a result of immune complex formation was again 
observed (Fig. 38b). This conclusively shows the binding of 
SLE anti-DNA antibodies to E2-BSA-DNA. 
Hxunan Autoantibody Binding to Estradiol 
Naturally occurring SLE autoantibodies with specificity 
for native DNA were checked for their binding with g-
estradiol using colorigenic and fluorogenic substrates. An 
SLE serum having high titer anti-DNA antibody activity 
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Fig.37. Inhibition of SLE anti-DNA antibody binding 
by native DNA (-X-'-O/A). DNA-BSA (-D-;-a-;-*^  
and E2-BSA-DNA (-#-;-Q-;^A-) . The polystyrene 
plate was coated with native DNA. 
131 
(a) (b-) I 
(a) Binding of 
analyzed by gel 
calf thymus DNA ( 
buffer (lane 
Fig.38. SLE IgG to native DNA as 
retardation assay. Native 
0.2 Jig) was incubated with 
1), and with varying 
concentrations of SLE IgG {5>ag, lane 2; lOpg, 
lane3; 15ug, lane4; 20ug, laneS). The complex 
was electrophoresed for 2 hr on 1% agarose. 
(b) Binding of SLE IgG to E2-BSA-DNA. The 
conjugate (0.2 ug) was incubated with buffer 
(lane 1) and with various concentrations of 
SLE IgG (Bug, lane2; lOug, lane3; 15ug, 
lane4; 20pg, laneS). The complex was 
electrophoresed for 2 hr on 1% agarose. 
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exhibited enhanced recognition of £-estradiol as compared to 
native DNA in ELISA experiments (Fig. 39). Six more SLE sera 
were checked for their binding with native DNA and S-
estradiol using colorigenic and fluorogenic substrates. It 
has been reported that the fluorogenic substrate increases 
the sensitivity of ELISA (Ali and Ali, 1983) . Figures 40 and 
41 show the enhanced binding of SLE anti-DNA autoantibodies 
with S-estradiol as compared to native DNA at 1:100 serum 
dilution in direct binding ELISA performed using PNP-P and 
4MU-P as the respective enzyme substrates. 
To further probe the binding of SLE anti-DNA antibodies 
with g-estradiol, SLE autoantibodies were affinity purified 
on DNA-Sepharose column. SLE sera were diluted 1:10 in PBS 
and passed through the column. After application of linear 
sodium chloride gradient the bound material eluted in two 
peaks (Fig. 42) . Colorimetric estimations and UV 
measurements revealed protein in peak 1 and DNA in peak 2. 
The absorbance ratio (^ 273/^ 251) of peak 1 fractions was 
found to be 2.47, typical of mammalian IgG. The affinity 
purified SLE IgG also showed enhanced binding with S-
estradiol as compared to native DNA using PNP-P as enzyme 
substrate (Fig. 43). 
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Fig.39. Direct binding assay of SLE 
autoantibodies. The plate was 
coated with native DNA (-Q—) and 
S-estradiol (-#-) . Binding with 
normal human serum (—A~) . 
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F i g . 4 1 . Binding of human SLE anti-DNA 
antibodies to na t ive DNA 
(-D—) and E-es t rad io l 
( - • - ) . The ELISA was 
performed using 4-methyl 
umbelliferyl phosphate as 
enzyme subs t r a t e . 
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Fig.42. Imnjunoaffinity purification of anti-native 
DNA antibodies on DNA-[polylysyl-Sepharose 
4B] column. Anti-DNA positive SLE serum was 
passed through the column and bound material 
was eluted with linear gradient ( ) of 
sodium chloride (0.15 to 3M) in 0.01 M Na-Pi 
buffer pH 7.4. Inset shows the results of 
Ouchterlony immunodiffusion. The central well 
(c) contained anti-human IgG. whereas 
peripheral wells l, 2 and 3 contained peak l, 
peak 2, and serum albumin. 
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Autoimmune diseases have been associated with a myriad 
of immunological abnormalities ranging from increased 
proinflammatory cytokines, decreased anti-inflammatory 
cytokines, increased expression of major histocompatibility 
complex molecules, skewing of T-cell receptor repertoire, 
increased numbers of B cells, and autoantibody production. 
It has been widely suspected that underlying all these 
immunological changes, there is a defect in the ability to 
eliminate self reactive T cells or B cells. Although much 
knowledge has accrued regarding various mechanisms that 
affect autoimmune disease, the exact causes and mechanisms 
of malfunction and tissue damage remain unclear. This 
failure is probably due to complex processes involved in 
immune recognition and regulation. Though a host of 
components that could lead to autoantibody production have 
been discovered, it appears that it will be the unraveling 
of the exact way in which these species interact that may 
actually lead to a complete understanding of autoimmune 
processes. The identification of the inciting antigen has 
been masked by three areas of ambiguity. First, it is 
uncertain whether identified autoantibodies and 
corresponding antigens have anything to do with the primary 
cause or pathogenesis of a given disease. Second, the immune 
diversity of autoantibodies observed in some diseases causes 
considerable difficulty in the identification of the 
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inciting antigen. Third, there is uncertainty as to whether 
the initial trigger has any relation to the antigen 
recognized by the autoantibodies (Plotz, 1992; Mongey and 
Hess, 1993; Levinson, 1994; Mountz et al., 1994; Radic and 
Weigert, 1994 and Theofilopoulos, 1995). 
The presence of antinuclear antibodies in the sera of 
patients suffering from various autoimmune disorders is of 
considerable importance. These naturally occurring 
antibodies not only provide diagnostic/prognostic parameters 
to clinicians but give molecular biologists valuable tools 
for the better understanding of cellular processes (Woodruff 
et al. , 1986; Pisetsky et al. , 1990). Amongst these 
antibodies those specific for DNA (anti-DNA antibodies) have 
received much attention as they are highly characteristic 
for SLE. Efforts to induce anti-DNA antibodies by 
immunization with native DNA have been unsuccessful 
indicating thereby that native DNA per se is not the 
immunogen for these antibodies. 
Despite considerable work that has been done to 
understand the pathogenesis of SLE, it is still unknown 
whether a single factor or more than one factor participate 
to initiate SLE (Frank et al. , 1990). The polyspecific 
binding of SLE autoantibodies to a whole gamut of modified 
nucleic acid conformers (Ali et al., 1991; Alam and Ali, 
1992; Alam et al. , 1992., 1993; Arjumand and Ali, 1994; 
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Klinman et al., 1994, and Moinuddin and Ali, 1994) has 
frustrated the efforts of lupus researchers to understand 
the origin and consequences of anti-ds DNA antibodies. It 
has long been recognised that more active iinmune responses 
and a higher incidence of autoimmune diseases occur in 
females (Lahita, 1985). Sex appears to be a potent risk 
factor as suggested by strong preponderance of SLE in 
females as compared to males, thus drawing immediate 
attention to the possible involvement of female sex hormones 
(Talal and Ahmad, 1987; Folomeev et al., 1990, 1992; Lahita, 
1992a, 1992b) . Estrogen has also been reported to be a 
potent disease accelarator in SLE prone MRL Ipr/lpr mice 
(Carlsten et al., 1990). Furthermore, elevated binding of 
estradiol to serum globulins was found in SLE patients and 
women who had taken oral contraceptives as compared to 
normal men and women (Counihan et al., 1991). 
In this study, two aspects were probed. One, the 
induction of Z-conformation in native calf thymus DNA as a 
result of bromination in high salt and by treatment with 
polyamines and second, the covalent modification of native 
DNA (average size 200 bp) by linking it to BSA and 
estradiol-albumin (E2-BSA)respectively. The possible role of 
these modified conformers in the pathogenesis of SLE has 
been investigated. 
The B->Z transition of synthetic polynucleotides as a 
141 
result of bromination in high salt has been well documented 
(Thomas et al., 1988). Bromination of double stranded DNA 
altered its UV absorption characteristics. The changes were 
more pronounced in the case of native DNA brominated in high 
salt compared to the polymer brominated in low salt. A large 
decrease in absorbance at 260 nm and increased absorbance at 
around 295 nm was observed in DNA brominated in high salt, 
while the polymer brominated under physiological conditions 
of saline did not show such marked changes in the UV 
spectrum. Moreover, the absorbance at around 300 nm in the 
difference spectrum was quite enhanced for native DNA 
brominated in high salt compared to the low salt sample. The 
spectra obtained in the case of DNA brominated in 4M NaCl 
are quite similar to the pattern exhibited by poly(dG-
dC).poly(dG-dC) when brominated in high salt, indicating 
thereby that native calf thymus DNA has attained Z or Z-like 
conformation. The absorbance ratio (A295/A2go) °f native DNA 
brominated in high salt was 0.35 while for the low salt 
brominated form, it was 0.188. This is also a parameter to 
judge the formation of Z-conformation because A295/A2go 
value for prototype Z-DNA is 0.3 and this value has been 
accepted as a characteristic of Z-conformation (Thomas and 
Strobel, 1988) . The results were also evaluated by circular 
dichroism studies wherein the inversion of spectrum in the 
case of DNA brominated in high salt provides additional 
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evidence for the attainment of Z-conformation. 
The barrier of interconversion of double stranded DNA 
between right handed and left handed helical forms was also 
challanged by polyamines, which are known to induce Z-
conformation in synthetic polynucleotides (Thomas et al., 
1990; Takeuchi et al., 1991). The importance of spermidine 
and spermine lies in their requirement for normal cell 
growth and differentiation. Their interaction with nucleic 
acids may be responsible, in part, for the biological 
function of polyamines. (Pegg, 1988). The transition of 
native B-form of DNA to Z-conformation in the presence of 
polyamines was checked by absorbance ratio and interaction 
with anti-Z-DNA antibodies. Taking into consideration the 
absorbance ratio (average 0.315) observed in case of 
poly(dG-dC).poly(dG-dC) and concentration of spermine 
required to achieve this conversion (40 iig/ml) , native calf 
thymus DNA indicated around 15% isomerization into Z-
conformation (average absorbance ratio was 0.125 at 100 
ug/ml of spermine). The specific binding of anti-Z-DNA 
antibody to polyamine-DNA complex is another evidence of 
conformational isomerization of native B-epitopes into Z-
conformation in the presence of increasing concentrations of 
spermine, spermidine and putrescine. Poly(dG-dC).poly(dG-dC) 
taken as a reference polymer showed similar epitope 
polymerization. Anti-Z-DNA antibody had no binding with 
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poly(dG-dC).poly(dG-dC) and native DNA when the 
polynucleotides were coated on the microtitre plate in the 
absence of polyamines. Monoclonal and polyclonal anti-Z-DNA 
antibodies have been used to detect the presence of left 
handed segments in natural DNAs (Arndt-Jovin et al., 1983; 
Lee et al., 1984; Nordheim et al., 1986). The solid phase 
enzyme immunoassay is a very sensitive technique to study 
the B->Z conformational transition of polynucleotides 
(Thomas et al., 1988). 
Native calf thymus DNA (average size 200 bp), obtained 
as a result of controlled digestion with micrococcal 
nuclease was covalently modified by linking with E2-BSA in 
order to see whether the female sex hormone, when conjugated 
to DNA, could form a possible antigenic trigger for SLE as 
the disease is more prevalent in women. The linked and 
unlinked species were separated by exclusion chromatography 
on Sephadex G-200 column. Two distinct peaks were obtained. 
However, colorimetric estimations could detect DNA only in 
the first peak while protein was present in both the peaks, 
implying that peak 1 contained E2-BSA-DNA conjugate. The 
altered spectral properties of DNA signify modifications 
in the double helix as a result of conjugate 
formation. 
The change in the absorbance ratio (A2go/A280^ from 2.2 
in case of DNA to l.6 for DNA-BSA conjugate and 1.45 for E2-
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BSA-DNA conjugate also suggests DNA modification as a result 
of conjugation. 
The modified nucleic acid polymers, with the exception 
of brominated DNA, because in this case the helix did not 
melt even at 100°C, were also characterised by thermal 
denaturation studies. While for native DNA the observed Tm 
was 87°C, it was 90*>C in the case of DNA-spermine complex. 
Moreover the DNA-spermine helix disruption started quite 
late (87.5°C) compared to native DNA. This means that the 
helix was resisting heat induced strand separation to a 
greater extent in case of DNA-spermine, meaning thereby that 
complexation of spermine has imparted stability to the DNA 
molecule. 
The E2-BSA-DNA and DNA-BSA conjugates were also 
characterised by thermal denaturation studies. The increased 
Tm value and decreased percent denaturation at 80°C in case 
of E2-BSA-DNA as compared to native DNA fragment indicates 
that E2-BSA-DNA is thermodynamically more stable than the 
corresponding native DNA fragments. On the contrary, the 
DNA-BSA conjugate was found to be less stable as judged by 
the decreased melting temperature and greatly increased 
percent denaturation at 80°C. The only difference between 
DNA-BSA and E2-BSA-DNA conjugate is the presence of 
estradiol molecule linked to BSA in the later species. Thus 
inference can be drawn that estradiol is somehow imparting 
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stc±)ility to the helix in E2-BSA-DNA conjugate. 
Additional evidence for the structural perturbations in 
native DNA and 200 bp DNA fragments as a consequence of 
interactions with protein, polyamine and hormone was 
gathered by computation of thermodynamic parameters. Native 
DNA displayed a large negative value for Gibb's free energy 
of denaturation (^  Gjj) till SB^C. The results depicted in 
Table 7 speculate the tremendous stability exhibited by 
double helical native DNA. Shift in A Gj-, value from negative 
to positive above 85°C suggest the disruption of Watson-
Crick base pairing and the transition of double helical 
nucleic acid from the native to denatured state. 
In comparison to native DNA, the DNA-spermine complex 
displayed negative A Cj-, values beyond 85°C suggesting that 
DNA-spermine complex is thermodynamically more stable than 
native DNA. This could be attributed to the fact that 
polyamine (spermine) having multiple positively charged 
amino groups interacts electrostatically or ionically with 
the negatively charged phosphate backbone of DNA and during 
the course of interaction, it encompasses the DNA 
macromolecule thereby enhancing helix stability. 
Apart from native DNA, the DNA fragments (average size 
200 bp) were also employed in this study to probe their 
interaction with BSA and E2-BSA respectively. In case of DNA 
fragments negative A Gj-, value was obtained only till lO^C 
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while for native DNA negative AQJ^ value persisted till 85°C 
implying thereby, that compared to native DNA, the 200 bp 
DNA fragments are thermodynamically less stable. The 
decreased stability of 200 bp fragments could be attributed 
to low G=C contents. In case of DNA-BSA conjugate, the 
negative ^ Gp values were observed only till 45°C. Thus a 
net difference of around 25°C was observed in the 
persistance of negative A Gj-, values when compared with the 
corresponding control (200 bp DNA) . The thermodynamic 
results speculate that a large portion in the DNA-BSA 
conjugate was already in the unstacked form. Clearly, the 
covalent conjugation of BSA with the amino groups of nucleic 
acid bases appears to completely obliterate the favourable 
A=T and G=C pairing interactions of the double helical DNA. 
The instability may be attributed to the conjugation of BSA 
to the potential sites or substrates in DNA rendering these 
conjugated sites in DNA topologically less constrained than 
the corresponding fully paired and fully stacked Watson-
Crick interactions. 
However, when estradiol-BSA was covalently linked to 
DNA fragments (-200 bp) , a totally different type of 
observation was recorded. In this case, surprisingly, large 
negative A Q-Q values were observed till 77"C of thermal 
supplementation. Thus, a priori to DNA-BSA, where 
destabilization was observed, entirely reversed results were 
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observed (tremendous stability) in the case of E2-BSA-DNA 
conjugate. The thermodynamic parameters suggest that, 
although the glutaraldehyde aided conjugation of BSA alone 
resulted in helix opening, the conjugation of E2-BSA has 
somehow stabilized the helix. The increased stability of 
this hormone-protein aducted DNA is suggestive of the 
formation of crosslinks in the 200 bp DNA macromolecule. The 
thermodynamic parameters observed here substantiate the mid-
point melting (Tm) data described earlier. 
The results of time dependent denaturation of native as 
well as modified nucleic acid were also interesting. The lag 
period shown by DNA-spermine complex was a bit larger as 
compared to native DNA indicating the induction of an 
additional kinetic barrier in native DNA as a consequence of 
ionic interaction with spermine. The increase in the ^i/o 
(half life) value for the denaturation of DNA-spermine 
complex in comparison to native DNA further substantiates 
the above argument. 
Native DNA fragments (average size 2 00 bp) exhibited a 
relatively shorter lag phase, thereby suggesting that the 
kinetic barrier for 2 00 bp DNA was relatively weaker than 
native DNA. On the contrary, DNA-BSA conjugate formed as a 
result of covalent conjugation by glutaraldehyde exhibited a 
minor transition but not the large lag period, perhaps due 
to the denaturation of a "segment" involving the conjugated 
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sites in the DNA-BSA conjugate, which consequently initiates 
the rapid denaturation of nucleic acid protein conjugate. 
The decrease in the half life i^i/2'^ ^°^ melting of DNA-BSA 
conjugate supports the above explanations. Surprisingly, 200 
bp DNA covalently linked to hormone protein (E2-BSA) 
conjugate exhibited a small increment over the lag period of 
native DNA (-200 bp) . This increase was substantial when 
compared to the lag period of DNA-BSA conjugate. This could 
be due to the introduction of a large kinetic barrier in the 
200 bp DNA as a result of E2-BSA conjugation, perhaps due to 
the formation of crosslinks in the helix. The increase in 
^1/2 ^ ° ^ melting of E2-BSA-DNA conjugate further 
siibstantiates the above argument. 
The E2-BSA, DNA-BSA and E2-BSA-DNA conjugates were 
found to be potent immunogens and induced high titre 
antibodies in rabbits. The induced antibodies were specific 
for their respective immunogens. The binding of anti-E2-BSA 
antibodies to E2-BSA-DNA and vice-versa clearly indicates 
that antibodies are recognizing common epitopes on these two 
antigens. The inhibition in the activity of anti-E2-BSA and 
anti-E2-BSA-DNA antibodies by estradiol is due to the 
presence of a small population of antibodies that is cross-
reactive with estradiol. None of the three antibodies showed 
inhibition with either poly(rG).poly(dC) or native calf 
thymus DNA brominated in high salt. The data indicates that 
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the antibodies are not recognizing either A/A-like or Z/Z-
like conformations meaning thereby that E2-BSA-DNA and DNA-
BSA conjugates have attained neither A-nor Z-conformation. 
The induced antibodies did not recognize native DNA. 
However, anti-E2-BSA-DNA antibodies were inhibited by heat 
denatured DNA (ssDNA) and RNA, but at a high inhibitor 
concentration (75 ng/ml), pointing towards the presence of a 
minor population of base specific antibodies. 
The recognition of various DNA conformations by SLE 
anti-DNA antibodies has got far reaching significance for 
the polyspecificity of SLE autoantibodies. The binding 
specificity of anti-DNA antibodies to various modified forms 
of DNA was analyzed by inhibition ELISA in which the ability 
of a competitor to block the DNA-autoantibody interaction is 
assessed. Human autoantibody recognition of the Z-
conformation induced either as a result of bromination in 
high salt or by polyamines (under physiological conditions 
of saline) is significant because Z-DNA can arise in vivo as 
a result of various molecular events and also, the formation 
of Z-DNA can be facilitated by protonated amines. It is 
worth while to mention here that significantly elevated 
levels of polyamines in the case of active SLE patients 
(Puri et al., 1978) can, in vivo, lead to the attainment of 
Z-conformation by native DNA. Since Z-DNA is highly 
immunogenic, the possibility of this polymer acting as 
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antigen for the production of human autoant ibodies cross-
reac t ive with na t ive DNA could be one of the fac to r s for the 
pathogenesis of SLE. 
A unique finding of t h i s study i s the binding of E2-
BSA-DNA conjugate to n a t u r a l l y occurring anti-DNA ant ibodies 
derived form the sera of SLE p a t i e n t s . 
The r e s u l t s i n d i c a t e d the r e c o g n i t i o n of a l t e r e d 
conformation of t he modif ied polymer. The E2-BSA-DNA 
conjugate was an e f fec t ive inh ib i to r in DNA-anti-DNA system. 
So f a r , the p o s s i b l e exp l ana t i ons put f o r t h for the 
production of anti-DNA autoantibodies have focussed mainly 
on the m o d i f i c a t i o n of DNA e i t h e r as a r e s u l t of 
environmental f ac to r s , hydroxyl/free r a d i c a l s , r ad i a t i ons or 
some other fac tors including genetic and v i r a l (Steinberg, 
1992; Ara and Al i , 1992; Theofilopoulous, 1995). I t i s qui te 
p o s s i b l e t h a t i n d i s e a s e d s t a t e t h e r e may be a l t e r e d 
conformation of es t radiol -DNA conjugate r e n d e r i n g the 
hormone-receptor-DNA complex as ' a l i e n ' t o t h e immune 
system, which might account for the predominance of SLE in 
females and a l s o fo r t he product ion of a n t i b o d i e s t h a t 
c r o s s - r e a c t wi th DNA. Compared to n a t i v e DNA, SLE 
autoantibodies exhib i ted enhanced binding to E -es t r ad io l in 
ELISA experiments performed by using both co lor igen ic and 
f luorogen ic s u b s t r a t e s . I t has been r e p o r t e d t h a t the 
fluorogenic subs t r a t e increases the s e n s i t i v i t y of ELISA 
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(Ali and Ali, 1983) . This provides further credence to the 
emerging hypothesis that native DNA is not the antigen 
responsible for the production of autoantibodies in SLE. 
This finding lends further support to the view that female 
sex hormone, might in one way or the other, be responsible 
for the production of lupus autoantibodies as the disease 
is more prevalent in women. It is possible that some sex 
hormonal disturbances that could occur as a result of 
contraceptive therapy, irregular menstrual cycle, child 
birth etc. might be contributing towards the production of 
autoantibodies. What appears from the studies undertaken so 
far and from the present work is that SLE is not a 
consequence of a single factor. The disease seems to be the 
result of various factors acting together or it is also 
possible that a single factor, might be leading to a chain 
of reactions involving other factors. The finding of Waters 
et al.(1992) wherein they have reported increased polyamine 
levels as a result of estradiol treatment to Atlantic salmon 
(Salmo salar), a fish, provides a direct relation between 
increased estradiol concentration and elevated polyamine 
levels in the body. If such a condition could also occur in 
humans than one might be able to explain and correlate the 
female predominance of SLE and the Z-DNA binding of anti-DNA 
antibodies from lupus patients, as it is well documented 
that high polyamine levels induce B-»Z transition. 
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Based on this study the following points of conclusion 
could be drawn : 
1. Induction of Z-conformation in native calf thymus DNA 
depends on its microenvironment. Z-DNA can be formed 
either by bromination in high sodium chloride 
concentration or as a result of polyamine interaction 
with DNA under physiological conditions of saline. Z-
conformation in native calf thymus DNA is maintained 
even when the high salt brominated polymer is dialyzed 
in a buffer containing 0.15 M NaCl. 
2. The binding of SLE anti-DNA antibodies to Z-conformer 
suggest that Z-DNA may be a potential putative 
autoantigen for the induction of antibodies cross-
reactive with native DNA. 
3. The modified forms, viz., DNA-spermine and E2-BSA-DNA 
conjugate are thermodynamically more stable than their 
respective controls, i.e native DNA and DNA 
fragment(-20Obp). 
4. The binding of naturally occurring autoantibodies to 
E2-BSA-DNA as well as the interaction of these 
antibodies with fi-estradiol clearly points towards the 
role of female sex-hormone in the pathogenesis of SLE. 
5. It is suggested that female sex-hormone, either alone 
or in conjugation with DNA, might be challenging the 
immune system leading to autoantibody production. 
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